BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1136788 CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(Br)cc1)C(C)(C)C InChI=1S/C22H29BrN4O4/c1-12(28)24-17(21(2,3)4)19(30)27-11-15(29)10-16(27)18-25-20(31)22(5,26-18)13-6-8-14(23)9-7-13/h6-9,15-17,29H,10-11H2,1-5H3,(H,24,28)(H,25,26,31)/t15-,16+,17-,22+/m1/s1 BXQUIQWJTNLTHH-SVQXRNPESA-N 536170 N-((2S)-1-((4R)-2-(5-(4-Bromophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)-4-hydroxypyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)acetamide::US11242344, Example 101.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >200000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536170&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 157494461 464921348 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136789 CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(Br)cc1)C(C)(C)C InChI=1S/C22H29BrN4O4/c1-12(28)24-17(21(2,3)4)19(30)27-11-15(29)10-16(27)18-25-20(31)22(5,26-18)13-6-8-14(23)9-7-13/h6-9,15-17,29H,10-11H2,1-5H3,(H,24,28)(H,25,26,31)/t15-,16+,17-,22+/m1/s1 BXQUIQWJTNLTHH-SVQXRNPESA-N 536170 N-((2S)-1-((4R)-2-(5-(4-Bromophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)-4-hydroxypyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)acetamide::US11242344, Example 101.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >500000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536170&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 157494461 464921348 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136790 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@H]1CCCN1S(C)(=O)=O InChI=1S/C24H29N5O5S2/c1-14-20(35-13-25-14)15-6-8-16(9-7-15)24(2)23(32)26-21(27-24)19-11-17(30)12-28(19)22(31)18-5-4-10-29(18)36(3,33)34/h6-9,13,17-19,30H,4-5,10-12H2,1-3H3,(H,26,27,32)/t17-,18-,19?,24+/m1/s1 JMHDAGHLLTXOHA-YXLVLPGXSA-N 536171 (5S)-2-((4R)-4-hydroxy-1-((methylsulfonyl)-D-prolyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 120.1::US11242344, Example 120.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536171&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572592 464921349 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136791 CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(Br)cc1)C(C)(C)C InChI=1S/C22H29BrN4O4/c1-12(28)24-17(21(2,3)4)19(30)27-11-15(29)10-16(27)18-25-20(31)22(5,26-18)13-6-8-14(23)9-7-13/h6-9,15-17,29H,10-11H2,1-5H3,(H,24,28)(H,25,26,31)/t15-,16+,17-,22-/m1/s1 BXQUIQWJTNLTHH-MPWIWIEXSA-N 536172 US11242344, Example 101.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >200000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536172&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 157494460 464921350 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136792 CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(Br)cc1)C(C)(C)C InChI=1S/C22H29BrN4O4/c1-12(28)24-17(21(2,3)4)19(30)27-11-15(29)10-16(27)18-25-20(31)22(5,26-18)13-6-8-14(23)9-7-13/h6-9,15-17,29H,10-11H2,1-5H3,(H,24,28)(H,25,26,31)/t15-,16+,17-,22-/m1/s1 BXQUIQWJTNLTHH-MPWIWIEXSA-N 536172 US11242344, Example 101.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 41600 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536172&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 157494460 464921350 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136793 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@H]1CCCN1S(C)(=O)=O InChI=1S/C24H29N5O5S2/c1-14-20(35-13-25-14)15-6-8-16(9-7-15)24(2)23(32)26-21(27-24)19-11-17(30)12-28(19)22(31)18-5-4-10-29(18)36(3,33)34/h6-9,13,17-19,30H,4-5,10-12H2,1-3H3,(H,26,27,32)/t17-,18-,19?,24+/m1/s1 JMHDAGHLLTXOHA-YXLVLPGXSA-N 536171 (5S)-2-((4R)-4-hydroxy-1-((methylsulfonyl)-D-prolyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 120.1::US11242344, Example 120.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536171&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572592 464921349 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136794 CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(Br)cc1)C(C)(C)C InChI=1S/C22H29BrN4O4/c1-12(28)24-17(21(2,3)4)19(30)27-11-15(29)10-16(27)18-25-20(31)22(5,26-18)13-6-8-14(23)9-7-13/h6-9,15-17,29H,10-11H2,1-5H3,(H,24,28)(H,25,26,31)/t15-,16-,17-,22+/m1/s1 BXQUIQWJTNLTHH-WBYLCXCBSA-N 536174 US11242344, Example 101.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >200000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536174&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572374 464921351 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136795 CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(Br)cc1)C(C)(C)C InChI=1S/C22H29BrN4O4/c1-12(28)24-17(21(2,3)4)19(30)27-11-15(29)10-16(27)18-25-20(31)22(5,26-18)13-6-8-14(23)9-7-13/h6-9,15-17,29H,10-11H2,1-5H3,(H,24,28)(H,25,26,31)/t15-,16-,17-,22+/m1/s1 BXQUIQWJTNLTHH-WBYLCXCBSA-N 536174 US11242344, Example 101.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 332000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536174&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572374 464921351 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136796 CC(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C25H29N5O4S/c1-14-21(35-13-26-14)16-6-8-17(9-7-16)25(3)24(34)27-22(28-25)20-11-18(32)12-30(20)23(33)19-5-4-10-29(19)15(2)31/h6-9,13,18-20,32H,4-5,10-12H2,1-3H3,(H,27,28,34)/t18-,19+,20?,25+/m1/s1 HMFVCLHXOSUBSF-CZXSMGFXSA-N 536175 (5S)-2-((4R)-1-(acetyl-L-prolyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 121.1::US11242344, Example 121.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 65500 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536175&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572358 464921352 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136797 CC(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C25H29N5O4S/c1-14-21(35-13-26-14)16-6-8-17(9-7-16)25(3)24(34)27-22(28-25)20-11-18(32)12-30(20)23(33)19-5-4-10-29(19)15(2)31/h6-9,13,18-20,32H,4-5,10-12H2,1-3H3,(H,27,28,34)/t18-,19+,20?,25+/m1/s1 HMFVCLHXOSUBSF-CZXSMGFXSA-N 536175 (5S)-2-((4R)-1-(acetyl-L-prolyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 121.1::US11242344, Example 121.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 29200 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536175&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572358 464921352 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136798 CC(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C25H29N5O4S/c1-14-21(35-13-26-14)16-6-8-17(9-7-16)25(3)24(34)27-22(28-25)20-11-18(32)12-30(20)23(33)19-5-4-10-29(19)15(2)31/h6-9,13,18-20,32H,4-5,10-12H2,1-3H3,(H,27,28,34)/t18-,19+,20?,25+/m1/s1 HMFVCLHXOSUBSF-CZXSMGFXSA-N 536175 (5S)-2-((4R)-1-(acetyl-L-prolyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 121.1::US11242344, Example 121.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536175&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572358 464921352 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136799 CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(Br)cc1)C(C)(C)C InChI=1S/C22H29BrN4O4/c1-12(28)24-17(21(2,3)4)19(30)27-11-15(29)10-16(27)18-25-20(31)22(5,26-18)13-6-8-14(23)9-7-13/h6-9,15-17,29H,10-11H2,1-5H3,(H,24,28)(H,25,26,31)/t15-,16-,17-,22-/m1/s1 BXQUIQWJTNLTHH-PEOGOYOCSA-N 536176 US11242344, Example 101.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 108000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536176&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572353 464921353 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136800 CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(Br)cc1)C(C)(C)C InChI=1S/C22H29BrN4O4/c1-12(28)24-17(21(2,3)4)19(30)27-11-15(29)10-16(27)18-25-20(31)22(5,26-18)13-6-8-14(23)9-7-13/h6-9,15-17,29H,10-11H2,1-5H3,(H,24,28)(H,25,26,31)/t15-,16-,17-,22-/m1/s1 BXQUIQWJTNLTHH-PEOGOYOCSA-N 536176 US11242344, Example 101.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 26700 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536176&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572353 464921353 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136801 CC(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C25H29N5O4S/c1-14-21(35-13-26-14)16-6-8-17(9-7-16)25(3)24(34)27-22(28-25)20-11-18(32)12-30(20)23(33)19-5-4-10-29(19)15(2)31/h6-9,13,18-20,32H,4-5,10-12H2,1-3H3,(H,27,28,34)/t18-,19+,20?,25+/m1/s1 HMFVCLHXOSUBSF-CZXSMGFXSA-N 536175 (5S)-2-((4R)-1-(acetyl-L-prolyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 121.1::US11242344, Example 121.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536175&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572358 464921352 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136802 CC(=O)N[C@H](C(=O)N1C[C@H](O)CC1C1=NC(=O)C(C)(N1)c1ccc(cc1)-c1scnc1C)C(C)(C)C InChI=1S/C26H33N5O4S/c1-14-20(36-13-27-14)16-7-9-17(10-8-16)26(6)24(35)29-22(30-26)19-11-18(33)12-31(19)23(34)21(25(3,4)5)28-15(2)32/h7-10,13,18-19,21,33H,11-12H2,1-6H3,(H,28,32)(H,29,30,35)/t18-,19?,21-,26?/m1/s1 VFYPZYMRUSSPCB-PFEPVGRASA-N 536178 N-((2S)-1-((4R)-4-Hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)acetamide (Single Stereoisomer)::US11242344, Example 102.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 6170 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536178&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 162468903 464921354 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136803 CC(=O)N[C@H](C(=O)N1C[C@H](O)CC1C1=NC(=O)C(C)(N1)c1ccc(cc1)-c1scnc1C)C(C)(C)C InChI=1S/C26H33N5O4S/c1-14-20(36-13-27-14)16-7-9-17(10-8-16)26(6)24(35)29-22(30-26)19-11-18(33)12-31(19)23(34)21(25(3,4)5)28-15(2)32/h7-10,13,18-19,21,33H,11-12H2,1-6H3,(H,28,32)(H,29,30,35)/t18-,19?,21-,26?/m1/s1 VFYPZYMRUSSPCB-PFEPVGRASA-N 536178 N-((2S)-1-((4R)-4-Hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)acetamide (Single Stereoisomer)::US11242344, Example 102.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 1960 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536178&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 162468903 464921354 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136804 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCCN1S(C)(=O)=O InChI=1S/C25H31N5O5S2/c1-15-21(36-14-26-15)16-7-9-17(10-8-16)25(2)24(33)27-22(28-25)20-12-18(31)13-29(20)23(32)19-6-4-5-11-30(19)37(3,34)35/h7-10,14,18-20,31H,4-6,11-13H2,1-3H3,(H,27,28,33)/t18-,19+,20?,25+/m1/s1 CALGLVXMWUUKJG-CZXSMGFXSA-N 536179 (5S)-2-((4R)-4-hydroxy-1-((S)-1-(methylsulfonyl)piperidine-2-carbonyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 122.1::US11242344, Example 122.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536179&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572827 464921355 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136805 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCCN1S(C)(=O)=O InChI=1S/C25H31N5O5S2/c1-15-21(36-14-26-15)16-7-9-17(10-8-16)25(2)24(33)27-22(28-25)20-12-18(31)13-29(20)23(32)19-6-4-5-11-30(19)37(3,34)35/h7-10,14,18-20,31H,4-6,11-13H2,1-3H3,(H,27,28,33)/t18-,19+,20?,25+/m1/s1 CALGLVXMWUUKJG-CZXSMGFXSA-N 536179 (5S)-2-((4R)-4-hydroxy-1-((S)-1-(methylsulfonyl)piperidine-2-carbonyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 122.1::US11242344, Example 122.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536179&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572827 464921355 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136806 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCCN1S(C)(=O)=O InChI=1S/C25H31N5O5S2/c1-15-21(36-14-26-15)16-7-9-17(10-8-16)25(2)24(33)27-22(28-25)20-12-18(31)13-29(20)23(32)19-6-4-5-11-30(19)37(3,34)35/h7-10,14,18-20,31H,4-6,11-13H2,1-3H3,(H,27,28,33)/t18-,19+,20?,25+/m1/s1 CALGLVXMWUUKJG-CZXSMGFXSA-N 536179 (5S)-2-((4R)-4-hydroxy-1-((S)-1-(methylsulfonyl)piperidine-2-carbonyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 122.1::US11242344, Example 122.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536179&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572827 464921355 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136807 CC(=O)N[C@H](C(=O)N1C[C@H](O)CC1C1=NC(=O)C(C)(N1)c1ccc(cc1)B1OC(C)(C)C(C)(C)O1)C(C)(C)C InChI=1S/C28H41BN4O6/c1-16(34)30-21(25(2,3)4)23(36)33-15-19(35)14-20(33)22-31-24(37)28(9,32-22)17-10-12-18(13-11-17)29-38-26(5,6)27(7,8)39-29/h10-13,19-21,35H,14-15H2,1-9H3,(H,30,34)(H,31,32,37)/t19-,20?,21-,28?/m1/s1 VPLHYGGQVCNXMG-KZLMFJTKSA-N 536180 N-((2S)-1-((4R)-2-(5-(4-Bromophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)-4-hydroxypyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)acetamide (2 Single Stereoisomers)::US11242344, Example 102.2::US11242344, Example 102.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 93100 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536180&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572725 464921356 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136808 CC(=O)N[C@H](C(=O)N1C[C@H](O)CC1C1=NC(=O)C(C)(N1)c1ccc(cc1)B1OC(C)(C)C(C)(C)O1)C(C)(C)C InChI=1S/C28H41BN4O6/c1-16(34)30-21(25(2,3)4)23(36)33-15-19(35)14-20(33)22-31-24(37)28(9,32-22)17-10-12-18(13-11-17)29-38-26(5,6)27(7,8)39-29/h10-13,19-21,35H,14-15H2,1-9H3,(H,30,34)(H,31,32,37)/t19-,20?,21-,28?/m1/s1 VPLHYGGQVCNXMG-KZLMFJTKSA-N 536180 N-((2S)-1-((4R)-2-(5-(4-Bromophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)-4-hydroxypyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)acetamide (2 Single Stereoisomers)::US11242344, Example 102.2::US11242344, Example 102.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 43800 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536180&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572725 464921356 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136809 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCCN1S(C)(=O)=O InChI=1S/C25H31N5O5S2/c1-15-21(36-14-26-15)16-7-9-17(10-8-16)25(2)24(33)27-22(28-25)20-12-18(31)13-29(20)23(32)19-6-4-5-11-30(19)37(3,34)35/h7-10,14,18-20,31H,4-6,11-13H2,1-3H3,(H,27,28,33)/t18-,19+,20?,25+/m1/s1 CALGLVXMWUUKJG-CZXSMGFXSA-N 536179 (5S)-2-((4R)-4-hydroxy-1-((S)-1-(methylsulfonyl)piperidine-2-carbonyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 122.1::US11242344, Example 122.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 16700 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536179&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572827 464921355 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136810 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCCN1S(C)(=O)=O InChI=1S/C25H31N5O5S2/c1-15-21(36-14-26-15)16-7-9-17(10-8-16)25(2)24(33)27-22(28-25)20-12-18(31)13-29(20)23(32)19-6-4-5-11-30(19)37(3,34)35/h7-10,14,18-20,31H,4-6,11-13H2,1-3H3,(H,27,28,33)/t18-,19+,20?,25+/m1/s1 CALGLVXMWUUKJG-CZXSMGFXSA-N 536179 (5S)-2-((4R)-4-hydroxy-1-((S)-1-(methylsulfonyl)piperidine-2-carbonyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 122.1::US11242344, Example 122.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 6830 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536179&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572827 464921355 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136811 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCCN1S(C)(=O)=O InChI=1S/C25H31N5O5S2/c1-15-21(36-14-26-15)16-7-9-17(10-8-16)25(2)24(33)27-22(28-25)20-12-18(31)13-29(20)23(32)19-6-4-5-11-30(19)37(3,34)35/h7-10,14,18-20,31H,4-6,11-13H2,1-3H3,(H,27,28,33)/t18-,19+,20?,25+/m1/s1 CALGLVXMWUUKJG-CZXSMGFXSA-N 536179 (5S)-2-((4R)-4-hydroxy-1-((S)-1-(methylsulfonyl)piperidine-2-carbonyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 122.1::US11242344, Example 122.2 von Hippel-Lindau disease tumor suppressor Human 39000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536179&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572827 464921355 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136812 CC(=O)N[C@H](C(=O)N1C[C@H](O)CC1C1=NC(=O)C(C)(N1)c1ccc(cc1)B1OC(C)(C)C(C)(C)O1)C(C)(C)C InChI=1S/C28H41BN4O6/c1-16(34)30-21(25(2,3)4)23(36)33-15-19(35)14-20(33)22-31-24(37)28(9,32-22)17-10-12-18(13-11-17)29-38-26(5,6)27(7,8)39-29/h10-13,19-21,35H,14-15H2,1-9H3,(H,30,34)(H,31,32,37)/t19-,20?,21-,28?/m1/s1 VPLHYGGQVCNXMG-KZLMFJTKSA-N 536180 N-((2S)-1-((4R)-2-(5-(4-Bromophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)-4-hydroxypyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)acetamide (2 Single Stereoisomers)::US11242344, Example 102.2::US11242344, Example 102.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 43300 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536180&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572725 464921356 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136813 CC(=O)N[C@H](C(=O)N1C[C@H](O)CC1C1=NC(=O)C(C)(N1)c1ccc(cc1)B1OC(C)(C)C(C)(C)O1)C(C)(C)C InChI=1S/C28H41BN4O6/c1-16(34)30-21(25(2,3)4)23(36)33-15-19(35)14-20(33)22-31-24(37)28(9,32-22)17-10-12-18(13-11-17)29-38-26(5,6)27(7,8)39-29/h10-13,19-21,35H,14-15H2,1-9H3,(H,30,34)(H,31,32,37)/t19-,20?,21-,28?/m1/s1 VPLHYGGQVCNXMG-KZLMFJTKSA-N 536180 N-((2S)-1-((4R)-2-(5-(4-Bromophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)-4-hydroxypyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)acetamide (2 Single Stereoisomers)::US11242344, Example 102.2::US11242344, Example 102.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 10700 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536180&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572725 464921356 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136814 CC(C)[C@H](N1Cc2ccccc2C1=O)C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C31H33N5O4S/c1-17(2)25(36-14-20-7-5-6-8-23(20)28(36)38)29(39)35-15-22(37)13-24(35)27-33-30(40)31(4,34-27)21-11-9-19(10-12-21)26-18(3)32-16-41-26/h5-12,16-17,22,24-25,37H,13-15H2,1-4H3,(H,33,34,40)/t22-,24?,25+,31+/m1/s1 ZERUXLRPTNAVAJ-HWSSKLHZSA-N 536183 2-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)isoindolin-1-one::US11242344, Example 123.1::US11242344, Example 123.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536183&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572653 464921357 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136815 CC(C)[C@H](N1Cc2ccccc2C1=O)C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C31H33N5O4S/c1-17(2)25(36-14-20-7-5-6-8-23(20)28(36)38)29(39)35-15-22(37)13-24(35)27-33-30(40)31(4,34-27)21-11-9-19(10-12-21)26-18(3)32-16-41-26/h5-12,16-17,22,24-25,37H,13-15H2,1-4H3,(H,33,34,40)/t22-,24?,25+,31+/m1/s1 ZERUXLRPTNAVAJ-HWSSKLHZSA-N 536183 2-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)isoindolin-1-one::US11242344, Example 123.1::US11242344, Example 123.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 55600 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536183&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572653 464921357 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136816 CC(C)[C@H](N1Cc2ccccc2C1=O)C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C31H33N5O4S/c1-17(2)25(36-14-20-7-5-6-8-23(20)28(36)38)29(39)35-15-22(37)13-24(35)27-33-30(40)31(4,34-27)21-11-9-19(10-12-21)26-18(3)32-16-41-26/h5-12,16-17,22,24-25,37H,13-15H2,1-4H3,(H,33,34,40)/t22-,24?,25+,31+/m1/s1 ZERUXLRPTNAVAJ-HWSSKLHZSA-N 536183 2-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)isoindolin-1-one::US11242344, Example 123.1::US11242344, Example 123.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536183&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572653 464921357 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136817 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C23H27BrN4O4/c1-12(2)19(18-9-13(3)27-32-18)21(30)28-11-16(29)10-17(28)20-25-22(31)23(4,26-20)14-5-7-15(24)8-6-14/h5-9,12,16-17,19,29H,10-11H2,1-4H3,(H,25,26,31)/t16-,17+,19?,23+/m1/s1 SSHCSPPIHNOWQB-VQVSVVCGSA-N 536184 5-(4-Bromophenyl)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 103.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536184&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407770 464921358 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136818 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C23H27BrN4O4/c1-12(2)19(18-9-13(3)27-32-18)21(30)28-11-16(29)10-17(28)20-25-22(31)23(4,26-20)14-5-7-15(24)8-6-14/h5-9,12,16-17,19,29H,10-11H2,1-4H3,(H,25,26,31)/t16-,17+,19?,23+/m1/s1 SSHCSPPIHNOWQB-VQVSVVCGSA-N 536184 5-(4-Bromophenyl)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 103.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536184&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407770 464921358 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136819 CC(C)[C@H](N1Cc2ccccc2C1=O)C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C31H33N5O4S/c1-17(2)25(36-14-20-7-5-6-8-23(20)28(36)38)29(39)35-15-22(37)13-24(35)27-33-30(40)31(4,34-27)21-11-9-19(10-12-21)26-18(3)32-16-41-26/h5-12,16-17,22,24-25,37H,13-15H2,1-4H3,(H,33,34,40)/t22-,24?,25+,31+/m1/s1 ZERUXLRPTNAVAJ-HWSSKLHZSA-N 536183 2-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)isoindolin-1-one::US11242344, Example 123.1::US11242344, Example 123.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 4680 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536183&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572653 464921357 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136820 CC(C)[C@H](N1Cc2ccccc2C1=O)C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C31H33N5O4S/c1-17(2)25(36-14-20-7-5-6-8-23(20)28(36)38)29(39)35-15-22(37)13-24(35)27-33-30(40)31(4,34-27)21-11-9-19(10-12-21)26-18(3)32-16-41-26/h5-12,16-17,22,24-25,37H,13-15H2,1-4H3,(H,33,34,40)/t22-,24?,25+,31+/m1/s1 ZERUXLRPTNAVAJ-HWSSKLHZSA-N 536183 2-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)isoindolin-1-one::US11242344, Example 123.1::US11242344, Example 123.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 3980 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536183&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572653 464921357 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136821 CC(C)[C@H](N1Cc2ccccc2C1=O)C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C31H33N5O4S/c1-17(2)25(36-14-20-7-5-6-8-23(20)28(36)38)29(39)35-15-22(37)13-24(35)27-33-30(40)31(4,34-27)21-11-9-19(10-12-21)26-18(3)32-16-41-26/h5-12,16-17,22,24-25,37H,13-15H2,1-4H3,(H,33,34,40)/t22-,24?,25+,31+/m1/s1 ZERUXLRPTNAVAJ-HWSSKLHZSA-N 536183 2-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)isoindolin-1-one::US11242344, Example 123.1::US11242344, Example 123.2 von Hippel-Lindau disease tumor suppressor Human 5480 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536183&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572653 464921357 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136822 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C23H27BrN4O4/c1-12(2)19(18-9-13(3)27-32-18)21(30)28-11-16(29)10-17(28)20-25-22(31)23(4,26-20)14-5-7-15(24)8-6-14/h5-9,12,16-17,19,29H,10-11H2,1-4H3,(H,25,26,31)/t16-,17+,19?,23-/m1/s1 SSHCSPPIHNOWQB-QVFUCISSSA-N 536186 US11242344, Example 103.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536186&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407771 464921359 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136823 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C23H27BrN4O4/c1-12(2)19(18-9-13(3)27-32-18)21(30)28-11-16(29)10-17(28)20-25-22(31)23(4,26-20)14-5-7-15(24)8-6-14/h5-9,12,16-17,19,29H,10-11H2,1-4H3,(H,25,26,31)/t16-,17+,19?,23-/m1/s1 SSHCSPPIHNOWQB-QVFUCISSSA-N 536186 US11242344, Example 103.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536186&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407771 464921359 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136824 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136825 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136826 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136827 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C23H27BrN4O4/c1-12(2)19(18-9-13(3)27-32-18)21(30)28-11-16(29)10-17(28)20-25-22(31)23(4,26-20)14-5-7-15(24)8-6-14/h5-9,12,16-17,19,29H,10-11H2,1-4H3,(H,25,26,31)/t16-,17-,19?,23+/m1/s1 SSHCSPPIHNOWQB-PDLMOSCPSA-N 536188 US11242344, Example 103.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 292000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536188&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407772 464921361 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136828 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C23H27BrN4O4/c1-12(2)19(18-9-13(3)27-32-18)21(30)28-11-16(29)10-17(28)20-25-22(31)23(4,26-20)14-5-7-15(24)8-6-14/h5-9,12,16-17,19,29H,10-11H2,1-4H3,(H,25,26,31)/t16-,17-,19?,23+/m1/s1 SSHCSPPIHNOWQB-PDLMOSCPSA-N 536188 US11242344, Example 103.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536188&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407772 464921361 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136829 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 32900 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136830 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 10100 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136831 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 von Hippel-Lindau disease tumor suppressor Human 54600 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136832 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C23H27BrN4O4/c1-12(2)19(18-9-13(3)27-32-18)21(30)28-11-16(29)10-17(28)20-25-22(31)23(4,26-20)14-5-7-15(24)8-6-14/h5-9,12,16-17,19,29H,10-11H2,1-4H3,(H,25,26,31)/t16-,17-,19?,23-/m1/s1 SSHCSPPIHNOWQB-BAEMNBJISA-N 536190 US11242344, Example 103.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 6730 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536190&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407773 464921362 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136833 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C23H27BrN4O4/c1-12(2)19(18-9-13(3)27-32-18)21(30)28-11-16(29)10-17(28)20-25-22(31)23(4,26-20)14-5-7-15(24)8-6-14/h5-9,12,16-17,19,29H,10-11H2,1-4H3,(H,25,26,31)/t16-,17-,19?,23-/m1/s1 SSHCSPPIHNOWQB-BAEMNBJISA-N 536190 US11242344, Example 103.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 1090 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536190&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407773 464921362 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136834 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136835 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136836 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136837 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C27H31N5O4S/c1-14(2)22(21-10-15(3)31-36-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-37-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20+,22?,27+/m1/s1 FSKZKSWIQLYFSC-GCGFIPRUSA-N 536192 2-((4R)-4-Hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl) pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1, 5-dihydro-4H-imidazol-4-one::US11242344, Example 104.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 203000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536192&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407774 464921363 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136838 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C27H31N5O4S/c1-14(2)22(21-10-15(3)31-36-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-37-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20+,22?,27+/m1/s1 FSKZKSWIQLYFSC-GCGFIPRUSA-N 536192 2-((4R)-4-Hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl) pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1, 5-dihydro-4H-imidazol-4-one::US11242344, Example 104.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 35900 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536192&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407774 464921363 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136839 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136840 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136841 CC(=O)N1CCCCC1C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C26H31N5O4S/c1-15-22(36-14-27-15)17-7-9-18(10-8-17)26(3)25(35)28-23(29-26)21-12-19(33)13-31(21)24(34)20-6-4-5-11-30(20)16(2)32/h7-10,14,19-21,33H,4-6,11-13H2,1-3H3,(H,28,29,35)/t19-,20?,21?,26+/m1/s1 KLRURTOFKMSXSW-QSLNHWLNSA-N 536187 (5S)-2-((4R)-1-(1-acetylpiperidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 124.1::US11242344, Example 124.2::US11242344, Example 124.3::US11242344, Example 124.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536187&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572568 464921360 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136842 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C27H31N5O4S/c1-14(2)22(21-10-15(3)31-36-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-37-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20+,22?,27-/m1/s1 FSKZKSWIQLYFSC-PCJGKADFSA-N 536194 US11242344, Example 104.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536194&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407775 464921364 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136843 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C27H31N5O4S/c1-14(2)22(21-10-15(3)31-36-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-37-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20+,22?,27-/m1/s1 FSKZKSWIQLYFSC-PCJGKADFSA-N 536194 US11242344, Example 104.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536194&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407775 464921364 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136844 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 179000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136845 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 14700 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136846 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136847 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C27H31N5O4S/c1-14(2)22(21-10-15(3)31-36-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-37-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20-,22?,27+/m1/s1 FSKZKSWIQLYFSC-GPCAASALSA-N 536196 US11242344, Example 104.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 230000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536196&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407776 464921366 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136848 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C27H31N5O4S/c1-14(2)22(21-10-15(3)31-36-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-37-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20-,22?,27+/m1/s1 FSKZKSWIQLYFSC-GPCAASALSA-N 536196 US11242344, Example 104.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 44600 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536196&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407776 464921366 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136849 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136850 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136851 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136852 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C27H31N5O4S/c1-14(2)22(21-10-15(3)31-36-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-37-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20-,22?,27-/m1/s1 FSKZKSWIQLYFSC-ZXHNHYDWSA-N 536198 US11242344, Example 104.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 422 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536198&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407777 464921367 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136853 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C27H31N5O4S/c1-14(2)22(21-10-15(3)31-36-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-37-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20-,22?,27-/m1/s1 FSKZKSWIQLYFSC-ZXHNHYDWSA-N 536198 US11242344, Example 104.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 171 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536198&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407777 464921367 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136854 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136855 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136856 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136857 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccnc1)c1cc(C)no1 InChI=1S/C28H31N5O4/c1-16(2)24(23-12-17(3)32-37-23)26(35)33-15-21(34)13-22(33)25-30-27(36)28(4,31-25)20-9-7-18(8-10-20)19-6-5-11-29-14-19/h5-12,14,16,21-22,24,34H,13,15H2,1-4H3,(H,30,31,36)/t21-,22+,24?,28+/m1/s1 DIXNBDVQUQMYDT-QOTJRUMNSA-N 536200 2-((4R)-4-Hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl) pyrrolidin-2-yl)-5-methyl-5-(4-(pyridin-3-yl) phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 105.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 375000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536200&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407778 464921368 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136858 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccnc1)c1cc(C)no1 InChI=1S/C28H31N5O4/c1-16(2)24(23-12-17(3)32-37-23)26(35)33-15-21(34)13-22(33)25-30-27(36)28(4,31-25)20-9-7-18(8-10-20)19-6-5-11-29-14-19/h5-12,14,16,21-22,24,34H,13,15H2,1-4H3,(H,30,31,36)/t21-,22+,24?,28+/m1/s1 DIXNBDVQUQMYDT-QOTJRUMNSA-N 536200 2-((4R)-4-Hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl) pyrrolidin-2-yl)-5-methyl-5-(4-(pyridin-3-yl) phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 105.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 241000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536200&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407778 464921368 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136859 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136860 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136861 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)C1N(CCC1(C)C)S(C)(=O)=O InChI=1S/C26H33N5O5S2/c1-15-20(37-14-27-15)16-6-8-17(9-7-16)26(4)24(34)28-22(29-26)19-12-18(32)13-30(19)23(33)21-25(2,3)10-11-31(21)38(5,35)36/h6-9,14,18-19,21,32H,10-13H2,1-5H3,(H,28,29,34)/t18-,19?,21?,26+/m1/s1 UOIWPPUAKKAFSI-ROLHBMJTSA-N 536195 (5S)-2-((4R)-1-(3,3-dimethyl-1-(methylsulfonyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 125.1::US11242344, Example 125.2::US11242344, Example 125.3::US11242344, Example 125.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536195&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572361 464921365 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136862 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccnc1)c1cc(C)no1 InChI=1S/C28H31N5O4/c1-16(2)24(23-12-17(3)32-37-23)26(35)33-15-21(34)13-22(33)25-30-27(36)28(4,31-25)20-9-7-18(8-10-20)19-6-5-11-29-14-19/h5-12,14,16,21-22,24,34H,13,15H2,1-4H3,(H,30,31,36)/t21-,22+,24?,28-/m1/s1 DIXNBDVQUQMYDT-UDRKPYGPSA-N 536202 US11242344, Example 105.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 136000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536202&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407779 464921369 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136863 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccnc1)c1cc(C)no1 InChI=1S/C28H31N5O4/c1-16(2)24(23-12-17(3)32-37-23)26(35)33-15-21(34)13-22(33)25-30-27(36)28(4,31-25)20-9-7-18(8-10-20)19-6-5-11-29-14-19/h5-12,14,16,21-22,24,34H,13,15H2,1-4H3,(H,30,31,36)/t21-,22+,24?,28-/m1/s1 DIXNBDVQUQMYDT-UDRKPYGPSA-N 536202 US11242344, Example 105.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 113000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536202&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407779 464921369 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136864 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(C)N1)c1cc(C)no1 InChI=1S/C17H26N4O4/c1-9(2)14(13-6-10(3)19-24-13)16(23)21-8-11(22)7-12(21)15-18-17(4,5)25-20-15/h6,9,11-12,14,22H,7-8H2,1-5H3,(H,18,20)/t11-,12+,14-/m1/s1 VHETVIJOIVHPMQ-MBNYWOFBSA-N 536203 (R)-1-((2S,4R)-2-(5,5-dimethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 126.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 31400 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536203&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 153049060 464921370 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136865 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(C)N1)c1cc(C)no1 InChI=1S/C17H26N4O4/c1-9(2)14(13-6-10(3)19-24-13)16(23)21-8-11(22)7-12(21)15-18-17(4,5)25-20-15/h6,9,11-12,14,22H,7-8H2,1-5H3,(H,18,20)/t11-,12+,14-/m1/s1 VHETVIJOIVHPMQ-MBNYWOFBSA-N 536203 (R)-1-((2S,4R)-2-(5,5-dimethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 126.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 12800 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536203&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 153049060 464921370 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136866 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(C)N1)c1cc(C)no1 InChI=1S/C17H26N4O4/c1-9(2)14(13-6-10(3)19-24-13)16(23)21-8-11(22)7-12(21)15-18-17(4,5)25-20-15/h6,9,11-12,14,22H,7-8H2,1-5H3,(H,18,20)/t11-,12+,14-/m1/s1 VHETVIJOIVHPMQ-MBNYWOFBSA-N 536203 (R)-1-((2S,4R)-2-(5,5-dimethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 126.1 von Hippel-Lindau disease tumor suppressor Human 45400 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536203&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 153049060 464921370 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136867 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccnc1)c1cc(C)no1 InChI=1S/C28H31N5O4/c1-16(2)24(23-12-17(3)32-37-23)26(35)33-15-21(34)13-22(33)25-30-27(36)28(4,31-25)20-9-7-18(8-10-20)19-6-5-11-29-14-19/h5-12,14,16,21-22,24,34H,13,15H2,1-4H3,(H,30,31,36)/t21-,22-,24?,28+/m1/s1 DIXNBDVQUQMYDT-ZQLROXLBSA-N 536204 US11242344, Example 105.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536204&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407780 464921371 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136868 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccnc1)c1cc(C)no1 InChI=1S/C28H31N5O4/c1-16(2)24(23-12-17(3)32-37-23)26(35)33-15-21(34)13-22(33)25-30-27(36)28(4,31-25)20-9-7-18(8-10-20)19-6-5-11-29-14-19/h5-12,14,16,21-22,24,34H,13,15H2,1-4H3,(H,30,31,36)/t21-,22-,24?,28+/m1/s1 DIXNBDVQUQMYDT-ZQLROXLBSA-N 536204 US11242344, Example 105.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536204&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407780 464921371 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136869 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(C)N1)c1cc(C)no1 InChI=1S/C17H26N4O4/c1-9(2)14(13-6-10(3)19-24-13)16(23)21-8-11(22)7-12(21)15-18-17(4,5)25-20-15/h6,9,11-12,14,22H,7-8H2,1-5H3,(H,18,20)/t11-,12+,14+/m1/s1 VHETVIJOIVHPMQ-DYEKYZERSA-N 536205 (S)-1-((2S,4R)-2-(5,5-dimethyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 126.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536205&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572902 464921372 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136870 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccnc1)c1cc(C)no1 InChI=1S/C28H31N5O4/c1-16(2)24(23-12-17(3)32-37-23)26(35)33-15-21(34)13-22(33)25-30-27(36)28(4,31-25)20-9-7-18(8-10-20)19-6-5-11-29-14-19/h5-12,14,16,21-22,24,34H,13,15H2,1-4H3,(H,30,31,36)/t21-,22-,24?,28-/m1/s1 DIXNBDVQUQMYDT-KRUXLVEUSA-N 536206 US11242344, Example 105.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 5390 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536206&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407781 464921373 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136871 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccnc1)c1cc(C)no1 InChI=1S/C28H31N5O4/c1-16(2)24(23-12-17(3)32-37-23)26(35)33-15-21(34)13-22(33)25-30-27(36)28(4,31-25)20-9-7-18(8-10-20)19-6-5-11-29-14-19/h5-12,14,16,21-22,24,34H,13,15H2,1-4H3,(H,30,31,36)/t21-,22-,24?,28-/m1/s1 DIXNBDVQUQMYDT-KRUXLVEUSA-N 536206 US11242344, Example 105.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 1580 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536206&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407781 464921373 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136872 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCCC2)N1)c1cc(C)no1 InChI=1S/C19H28N4O4/c1-11(2)16(15-8-12(3)21-26-15)18(25)23-10-13(24)9-14(23)17-20-19(27-22-17)6-4-5-7-19/h8,11,13-14,16,24H,4-7,9-10H2,1-3H3,(H,20,22)/t13-,14+,16+/m1/s1 AGJJNPYHMLNPDT-YCPHGPKFSA-N 536207 (S)-1-((2S,4R)-4-hydroxy-2-(1-oxa-2,4-diazaspiro[4.4]non-2-en-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 127.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536207&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572523 464921374 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136873 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCCC2)N1)c1cc(C)no1 InChI=1S/C19H28N4O4/c1-11(2)16(15-8-12(3)21-26-15)18(25)23-10-13(24)9-14(23)17-20-19(27-22-17)6-4-5-7-19/h8,11,13-14,16,24H,4-7,9-10H2,1-3H3,(H,20,22)/t13-,14+,16+/m1/s1 AGJJNPYHMLNPDT-YCPHGPKFSA-N 536207 (S)-1-((2S,4R)-4-hydroxy-2-(1-oxa-2,4-diazaspiro[4.4]non-2-en-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 127.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536207&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572523 464921374 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136874 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCCC2)N1)c1cc(C)no1 InChI=1S/C19H28N4O4/c1-11(2)16(15-8-12(3)21-26-15)18(25)23-10-13(24)9-14(23)17-20-19(27-22-17)6-4-5-7-19/h8,11,13-14,16,24H,4-7,9-10H2,1-3H3,(H,20,22)/t13-,14+,16+/m1/s1 AGJJNPYHMLNPDT-YCPHGPKFSA-N 536207 (S)-1-((2S,4R)-4-hydroxy-2-(1-oxa-2,4-diazaspiro[4.4]non-2-en-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 127.1 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536207&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572523 464921374 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136875 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccnc1C)c1cc(C)no1 InChI=1S/C29H33N5O4/c1-16(2)25(24-13-17(3)33-38-24)27(36)34-15-21(35)14-23(34)26-31-28(37)29(5,32-26)20-10-8-19(9-11-20)22-7-6-12-30-18(22)4/h6-13,16,21,23,25,35H,14-15H2,1-5H3,(H,31,32,37)/t21-,23+,25?,29+/m1/s1 WPZOEZCNSSMQBG-HXJDQFTHSA-N 536208 2-((4R)-4-Hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(2-methylpyridin-3-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 106.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536208&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407782 464921375 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136876 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccnc1C)c1cc(C)no1 InChI=1S/C29H33N5O4/c1-16(2)25(24-13-17(3)33-38-24)27(36)34-15-21(35)14-23(34)26-31-28(37)29(5,32-26)20-10-8-19(9-11-20)22-7-6-12-30-18(22)4/h6-13,16,21,23,25,35H,14-15H2,1-5H3,(H,31,32,37)/t21-,23+,25?,29+/m1/s1 WPZOEZCNSSMQBG-HXJDQFTHSA-N 536208 2-((4R)-4-Hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(2-methylpyridin-3-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 106.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536208&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407782 464921375 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136877 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCCC2)N1)c1cc(C)no1 InChI=1S/C19H28N4O4/c1-11(2)16(15-8-12(3)21-26-15)18(25)23-10-13(24)9-14(23)17-20-19(27-22-17)6-4-5-7-19/h8,11,13-14,16,24H,4-7,9-10H2,1-3H3,(H,20,22)/t13-,14+,16-/m1/s1 AGJJNPYHMLNPDT-IJEWVQPXSA-N 536209 (R)-1-((2S,4R)-4-hydroxy-2-(1-oxa-2,4-diazaspiro[4.4]non-2-en-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 127.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 50800 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536209&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 157106624 464921376 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136878 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCCC2)N1)c1cc(C)no1 InChI=1S/C19H28N4O4/c1-11(2)16(15-8-12(3)21-26-15)18(25)23-10-13(24)9-14(23)17-20-19(27-22-17)6-4-5-7-19/h8,11,13-14,16,24H,4-7,9-10H2,1-3H3,(H,20,22)/t13-,14+,16-/m1/s1 AGJJNPYHMLNPDT-IJEWVQPXSA-N 536209 (R)-1-((2S,4R)-4-hydroxy-2-(1-oxa-2,4-diazaspiro[4.4]non-2-en-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 127.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 16400 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536209&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 157106624 464921376 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136879 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCCC2)N1)c1cc(C)no1 InChI=1S/C19H28N4O4/c1-11(2)16(15-8-12(3)21-26-15)18(25)23-10-13(24)9-14(23)17-20-19(27-22-17)6-4-5-7-19/h8,11,13-14,16,24H,4-7,9-10H2,1-3H3,(H,20,22)/t13-,14+,16-/m1/s1 AGJJNPYHMLNPDT-IJEWVQPXSA-N 536209 (R)-1-((2S,4R)-4-hydroxy-2-(1-oxa-2,4-diazaspiro[4.4]non-2-en-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 127.2 von Hippel-Lindau disease tumor suppressor Human 73200 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536209&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 157106624 464921376 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136880 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccnc1C)c1cc(C)no1 InChI=1S/C29H33N5O4/c1-16(2)25(24-13-17(3)33-38-24)27(36)34-15-21(35)14-23(34)26-31-28(37)29(5,32-26)20-10-8-19(9-11-20)22-7-6-12-30-18(22)4/h6-13,16,21,23,25,35H,14-15H2,1-5H3,(H,31,32,37)/t21-,23-,25?,29-/m1/s1 WPZOEZCNSSMQBG-DTHKXDAOSA-N 536210 US11242344, Example 106.2::US11242344, Example 106.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536210&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407783 464921377 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136881 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccnc1C)c1cc(C)no1 InChI=1S/C29H33N5O4/c1-16(2)25(24-13-17(3)33-38-24)27(36)34-15-21(35)14-23(34)26-31-28(37)29(5,32-26)20-10-8-19(9-11-20)22-7-6-12-30-18(22)4/h6-13,16,21,23,25,35H,14-15H2,1-5H3,(H,31,32,37)/t21-,23-,25?,29-/m1/s1 WPZOEZCNSSMQBG-DTHKXDAOSA-N 536210 US11242344, Example 106.2::US11242344, Example 106.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536210&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407783 464921377 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136882 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccccc1)c1cc(C)no1 InChI=1S/C22H28N4O4/c1-13(2)19(18-10-14(3)24-29-18)21(28)26-12-16(27)11-17(26)20-23-22(4,30-25-20)15-8-6-5-7-9-15/h5-10,13,16-17,19,27H,11-12H2,1-4H3,(H,23,25)/t16-,17+,19+,22?/m1/s1 GCHCNRGXKCLUIW-OZICTILFSA-N 536211 (2S)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 128.1::US11242344, Example 128.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536211&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572335 464921378 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136883 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccnc1C)c1cc(C)no1 InChI=1S/C29H33N5O4/c1-16(2)25(24-13-17(3)33-38-24)27(36)34-15-21(35)14-23(34)26-31-28(37)29(5,32-26)20-10-8-19(9-11-20)22-7-6-12-30-18(22)4/h6-13,16,21,23,25,35H,14-15H2,1-5H3,(H,31,32,37)/t21-,23-,25?,29+/m1/s1 WPZOEZCNSSMQBG-AFQHRHPCSA-N 536212 US11242344, Example 106.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536212&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407784 464921379 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136884 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccnc1C)c1cc(C)no1 InChI=1S/C29H33N5O4/c1-16(2)25(24-13-17(3)33-38-24)27(36)34-15-21(35)14-23(34)26-31-28(37)29(5,32-26)20-10-8-19(9-11-20)22-7-6-12-30-18(22)4/h6-13,16,21,23,25,35H,14-15H2,1-5H3,(H,31,32,37)/t21-,23-,25?,29+/m1/s1 WPZOEZCNSSMQBG-AFQHRHPCSA-N 536212 US11242344, Example 106.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536212&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407784 464921379 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136885 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccccc1)c1cc(C)no1 InChI=1S/C22H28N4O4/c1-13(2)19(18-10-14(3)24-29-18)21(28)26-12-16(27)11-17(26)20-23-22(4,30-25-20)15-8-6-5-7-9-15/h5-10,13,16-17,19,27H,11-12H2,1-4H3,(H,23,25)/t16-,17+,19+,22?/m1/s1 GCHCNRGXKCLUIW-OZICTILFSA-N 536211 (2S)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 128.1::US11242344, Example 128.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536211&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572335 464921378 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136886 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccnc1C)c1cc(C)no1 InChI=1S/C29H33N5O4/c1-16(2)25(24-13-17(3)33-38-24)27(36)34-15-21(35)14-23(34)26-31-28(37)29(5,32-26)20-10-8-19(9-11-20)22-7-6-12-30-18(22)4/h6-13,16,21,23,25,35H,14-15H2,1-5H3,(H,31,32,37)/t21-,23-,25?,29-/m1/s1 WPZOEZCNSSMQBG-DTHKXDAOSA-N 536210 US11242344, Example 106.2::US11242344, Example 106.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 2960 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536210&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407783 464921377 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136887 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccnc1C)c1cc(C)no1 InChI=1S/C29H33N5O4/c1-16(2)25(24-13-17(3)33-38-24)27(36)34-15-21(35)14-23(34)26-31-28(37)29(5,32-26)20-10-8-19(9-11-20)22-7-6-12-30-18(22)4/h6-13,16,21,23,25,35H,14-15H2,1-5H3,(H,31,32,37)/t21-,23-,25?,29-/m1/s1 WPZOEZCNSSMQBG-DTHKXDAOSA-N 536210 US11242344, Example 106.2::US11242344, Example 106.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 895 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536210&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407783 464921377 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136888 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccccc1)c1cc(C)no1 InChI=1S/C22H28N4O4/c1-13(2)19(18-10-14(3)24-29-18)21(28)26-12-16(27)11-17(26)20-23-22(4,30-25-20)15-8-6-5-7-9-15/h5-10,13,16-17,19,27H,11-12H2,1-4H3,(H,23,25)/t16-,17+,19-,22?/m1/s1 GCHCNRGXKCLUIW-NOGMPNEWSA-N 536215 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 128.3::US11242344, Example 128.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 33600 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536215&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572768 464921380 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136889 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccccc1)c1cc(C)no1 InChI=1S/C22H28N4O4/c1-13(2)19(18-10-14(3)24-29-18)21(28)26-12-16(27)11-17(26)20-23-22(4,30-25-20)15-8-6-5-7-9-15/h5-10,13,16-17,19,27H,11-12H2,1-4H3,(H,23,25)/t16-,17+,19-,22?/m1/s1 GCHCNRGXKCLUIW-NOGMPNEWSA-N 536215 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 128.3::US11242344, Example 128.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 5700 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536215&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572768 464921380 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136890 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccccc1)c1cc(C)no1 InChI=1S/C22H28N4O4/c1-13(2)19(18-10-14(3)24-29-18)21(28)26-12-16(27)11-17(26)20-23-22(4,30-25-20)15-8-6-5-7-9-15/h5-10,13,16-17,19,27H,11-12H2,1-4H3,(H,23,25)/t16-,17+,19-,22?/m1/s1 GCHCNRGXKCLUIW-NOGMPNEWSA-N 536215 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 128.3::US11242344, Example 128.4 von Hippel-Lindau disease tumor suppressor Human 10700 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536215&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572768 464921380 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136891 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)C(C)(C)N1)c1cc(C)no1 InChI=1S/C18H26N4O4/c1-9(2)14(13-6-10(3)21-26-13)16(24)22-8-11(23)7-12(22)15-19-17(25)18(4,5)20-15/h6,9,11-12,14,23H,7-8H2,1-5H3,(H,19,20,25)/t11-,12+,14-/m1/s1 VEGOWGIYNZHSAH-MBNYWOFBSA-N 536216 2-((4R)-4-Hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl) butanoyl)pyrrolidin-2-yl)-5,5-dimethyl-1H-imidazol-4(5H)-one::US11242344, Example 107.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536216&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 161274592 464921381 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136892 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccccc1)c1cc(C)no1 InChI=1S/C22H28N4O4/c1-13(2)19(18-10-14(3)24-29-18)21(28)26-12-16(27)11-17(26)20-23-22(4,30-25-20)15-8-6-5-7-9-15/h5-10,13,16-17,19,27H,11-12H2,1-4H3,(H,23,25)/t16-,17+,19-,22?/m1/s1 GCHCNRGXKCLUIW-NOGMPNEWSA-N 536215 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 128.3::US11242344, Example 128.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 17300 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536215&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572768 464921380 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136893 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccccc1)c1cc(C)no1 InChI=1S/C22H28N4O4/c1-13(2)19(18-10-14(3)24-29-18)21(28)26-12-16(27)11-17(26)20-23-22(4,30-25-20)15-8-6-5-7-9-15/h5-10,13,16-17,19,27H,11-12H2,1-4H3,(H,23,25)/t16-,17+,19-,22?/m1/s1 GCHCNRGXKCLUIW-NOGMPNEWSA-N 536215 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 128.3::US11242344, Example 128.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 7500 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536215&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572768 464921380 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136894 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccccc1)c1cc(C)no1 InChI=1S/C22H28N4O4/c1-13(2)19(18-10-14(3)24-29-18)21(28)26-12-16(27)11-17(26)20-23-22(4,30-25-20)15-8-6-5-7-9-15/h5-10,13,16-17,19,27H,11-12H2,1-4H3,(H,23,25)/t16-,17+,19-,22?/m1/s1 GCHCNRGXKCLUIW-NOGMPNEWSA-N 536215 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 128.3::US11242344, Example 128.4 von Hippel-Lindau disease tumor suppressor Human 24500 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536215&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572768 464921380 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136895 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)C(C)(C)N1)c1cc(C)no1 InChI=1S/C18H26N4O4/c1-9(2)14(13-6-10(3)21-26-13)16(24)22-8-11(23)7-12(22)15-19-17(25)18(4,5)20-15/h6,9,11-12,14,23H,7-8H2,1-5H3,(H,19,20,25)/t11-,12-,14-/m1/s1 VEGOWGIYNZHSAH-YRGRVCCFSA-N 536218 US11242344, Example 107.2::US11242344, Example 107.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 24100 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536218&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572675 464921382 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136896 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)C(C)(C)N1)c1cc(C)no1 InChI=1S/C18H26N4O4/c1-9(2)14(13-6-10(3)21-26-13)16(24)22-8-11(23)7-12(22)15-19-17(25)18(4,5)20-15/h6,9,11-12,14,23H,7-8H2,1-5H3,(H,19,20,25)/t11-,12-,14-/m1/s1 VEGOWGIYNZHSAH-YRGRVCCFSA-N 536218 US11242344, Example 107.2::US11242344, Example 107.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 14900 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536218&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572675 464921382 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136897 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22+,26?/m1/s1 SJWOQSNEWHFLAZ-DOCVTQSRSA-N 536219 (2S)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.1::US11242344, Example 129.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 79000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536219&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572399 464921383 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136898 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22+,26?/m1/s1 SJWOQSNEWHFLAZ-DOCVTQSRSA-N 536219 (2S)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.1::US11242344, Example 129.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 48100 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536219&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572399 464921383 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136899 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22+,26?/m1/s1 SJWOQSNEWHFLAZ-DOCVTQSRSA-N 536219 (2S)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.1::US11242344, Example 129.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536219&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572399 464921383 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136900 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)C(C)(C)N1)c1cc(C)no1 InChI=1S/C18H26N4O4/c1-9(2)14(13-6-10(3)21-26-13)16(24)22-8-11(23)7-12(22)15-19-17(25)18(4,5)20-15/h6,9,11-12,14,23H,7-8H2,1-5H3,(H,19,20,25)/t11-,12-,14-/m1/s1 VEGOWGIYNZHSAH-YRGRVCCFSA-N 536218 US11242344, Example 107.2::US11242344, Example 107.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >50000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536218&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572675 464921382 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136901 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)C(C)(C)N1)c1cc(C)no1 InChI=1S/C18H26N4O4/c1-9(2)14(13-6-10(3)21-26-13)16(24)22-8-11(23)7-12(22)15-19-17(25)18(4,5)20-15/h6,9,11-12,14,23H,7-8H2,1-5H3,(H,19,20,25)/t11-,12-,14-/m1/s1 VEGOWGIYNZHSAH-YRGRVCCFSA-N 536218 US11242344, Example 107.2::US11242344, Example 107.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536218&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572675 464921382 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136902 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22+,26?/m1/s1 SJWOQSNEWHFLAZ-DOCVTQSRSA-N 536219 (2S)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.1::US11242344, Example 129.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 58400 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536219&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572399 464921383 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136903 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22+,26?/m1/s1 SJWOQSNEWHFLAZ-DOCVTQSRSA-N 536219 (2S)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.1::US11242344, Example 129.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 57000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536219&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572399 464921383 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136904 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22+,26?/m1/s1 SJWOQSNEWHFLAZ-DOCVTQSRSA-N 536219 (2S)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.1::US11242344, Example 129.2 von Hippel-Lindau disease tumor suppressor Human 77900 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536219&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572399 464921383 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136905 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)C(C)(C)N1)c1cc(C)no1 InChI=1S/C18H26N4O4/c1-9(2)14(13-6-10(3)21-26-13)16(24)22-8-11(23)7-12(22)15-19-17(25)18(4,5)20-15/h6,9,11-12,14,23H,7-8H2,1-5H3,(H,19,20,25)/t11-,12-,14+/m1/s1 VEGOWGIYNZHSAH-BZPMIXESSA-N 536222 US11242344, Example 107.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >50000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536222&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572874 464921384 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136906 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)C(C)(C)N1)c1cc(C)no1 InChI=1S/C18H26N4O4/c1-9(2)14(13-6-10(3)21-26-13)16(24)22-8-11(23)7-12(22)15-19-17(25)18(4,5)20-15/h6,9,11-12,14,23H,7-8H2,1-5H3,(H,19,20,25)/t11-,12-,14+/m1/s1 VEGOWGIYNZHSAH-BZPMIXESSA-N 536222 US11242344, Example 107.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536222&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572874 464921384 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136907 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22-,26?/m1/s1 SJWOQSNEWHFLAZ-SACATOBUSA-N 536223 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.3::US11242344, Example 129.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 418 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536223&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572686 464921385 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136908 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22-,26?/m1/s1 SJWOQSNEWHFLAZ-SACATOBUSA-N 536223 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.3::US11242344, Example 129.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 29.3 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536223&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572686 464921385 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136909 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22-,26?/m1/s1 SJWOQSNEWHFLAZ-SACATOBUSA-N 536223 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.3::US11242344, Example 129.4 von Hippel-Lindau disease tumor suppressor Human 304 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536223&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572686 464921385 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136910 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccc(=O)n1C)c1cc(C)no1 InChI=1S/C29H33N5O5/c1-16(2)25(23-13-17(3)32-39-23)27(37)34-15-20(35)14-22(34)26-30-28(38)29(4,31-26)19-11-9-18(10-12-19)21-7-6-8-24(36)33(21)5/h6-13,16,20,22,25,35H,14-15H2,1-5H3,(H,30,31,38)/t20-,22+,25?,29+/m1/s1 NVXRTBAQPIGSRM-PQHMZMEASA-N 536224 6-(4-(2-((4R)-4-Hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl) pyrrolidin-2-yl)-5-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl) phenyl)-1-methylpyridin-2(1H)-one::US11242344, Example 108.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 57500 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536224&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407785 464921386 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136911 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccc(=O)n1C)c1cc(C)no1 InChI=1S/C29H33N5O5/c1-16(2)25(23-13-17(3)32-39-23)27(37)34-15-20(35)14-22(34)26-30-28(38)29(4,31-26)19-11-9-18(10-12-19)21-7-6-8-24(36)33(21)5/h6-13,16,20,22,25,35H,14-15H2,1-5H3,(H,30,31,38)/t20-,22+,25?,29+/m1/s1 NVXRTBAQPIGSRM-PQHMZMEASA-N 536224 6-(4-(2-((4R)-4-Hydroxy-1-(3-methyl-2-(3-methylisoxazol-5-yl)butanoyl) pyrrolidin-2-yl)-5-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl) phenyl)-1-methylpyridin-2(1H)-one::US11242344, Example 108.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 13900 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536224&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407785 464921386 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136912 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22-,26?/m1/s1 SJWOQSNEWHFLAZ-SACATOBUSA-N 536223 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.3::US11242344, Example 129.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 202 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536223&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572686 464921385 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136913 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22-,26?/m1/s1 SJWOQSNEWHFLAZ-SACATOBUSA-N 536223 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.3::US11242344, Example 129.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 43.8 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536223&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572686 464921385 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136914 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)no1 InChI=1S/C26H31N5O4S/c1-14(2)22(21-10-15(3)29-34-21)25(33)31-12-19(32)11-20(31)24-28-26(5,35-30-24)18-8-6-17(7-9-18)23-16(4)27-13-36-23/h6-10,13-14,19-20,22,32H,11-12H2,1-5H3,(H,28,30)/t19-,20+,22-,26?/m1/s1 SJWOQSNEWHFLAZ-SACATOBUSA-N 536223 (2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 129.3::US11242344, Example 129.4 von Hippel-Lindau disease tumor suppressor Human 239 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536223&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572686 464921385 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136915 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccc(=O)n1C)c1cc(C)no1 InChI=1S/C29H33N5O5/c1-16(2)25(23-13-17(3)32-39-23)27(37)34-15-20(35)14-22(34)26-30-28(38)29(4,31-26)19-11-9-18(10-12-19)21-7-6-8-24(36)33(21)5/h6-13,16,20,22,25,35H,14-15H2,1-5H3,(H,30,31,38)/t20-,22+,25?,29-/m1/s1 NVXRTBAQPIGSRM-FNPDAKPFSA-N 536226 US11242344, Example 108.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 11000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536226&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407786 464921387 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136916 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccc(=O)n1C)c1cc(C)no1 InChI=1S/C29H33N5O5/c1-16(2)25(23-13-17(3)32-39-23)27(37)34-15-20(35)14-22(34)26-30-28(38)29(4,31-26)19-11-9-18(10-12-19)21-7-6-8-24(36)33(21)5/h6-13,16,20,22,25,35H,14-15H2,1-5H3,(H,30,31,38)/t20-,22+,25?,29-/m1/s1 NVXRTBAQPIGSRM-FNPDAKPFSA-N 536226 US11242344, Example 108.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 3950 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536226&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407786 464921387 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136917 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20+,23?/m1/s1 JNTHBMXTLMHJGI-RIBUYDGZSA-N 536227 (2S)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.1::US11242344, Example 130.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 96100 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536227&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572518 464921388 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136918 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20+,23?/m1/s1 JNTHBMXTLMHJGI-RIBUYDGZSA-N 536227 (2S)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.1::US11242344, Example 130.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 83000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536227&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572518 464921388 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136919 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20+,23?/m1/s1 JNTHBMXTLMHJGI-RIBUYDGZSA-N 536227 (2S)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.1::US11242344, Example 130.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536227&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572518 464921388 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136920 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccc(=O)n1C)c1cc(C)no1 InChI=1S/C29H33N5O5/c1-16(2)25(23-13-17(3)32-39-23)27(37)34-15-20(35)14-22(34)26-30-28(38)29(4,31-26)19-11-9-18(10-12-19)21-7-6-8-24(36)33(21)5/h6-13,16,20,22,25,35H,14-15H2,1-5H3,(H,30,31,38)/t20-,22-,25?,29+/m1/s1 NVXRTBAQPIGSRM-XOMQAJFSSA-N 536228 US11242344, Example 108.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536228&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407787 464921389 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136921 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1cccc(=O)n1C)c1cc(C)no1 InChI=1S/C29H33N5O5/c1-16(2)25(23-13-17(3)32-39-23)27(37)34-15-20(35)14-22(34)26-30-28(38)29(4,31-26)19-11-9-18(10-12-19)21-7-6-8-24(36)33(21)5/h6-13,16,20,22,25,35H,14-15H2,1-5H3,(H,30,31,38)/t20-,22-,25?,29+/m1/s1 NVXRTBAQPIGSRM-XOMQAJFSSA-N 536228 US11242344, Example 108.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >300 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536228&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407787 464921389 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136922 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20+,23?/m1/s1 JNTHBMXTLMHJGI-RIBUYDGZSA-N 536227 (2S)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.1::US11242344, Example 130.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 362000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536227&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572518 464921388 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136923 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20+,23?/m1/s1 JNTHBMXTLMHJGI-RIBUYDGZSA-N 536227 (2S)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.1::US11242344, Example 130.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 121000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536227&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572518 464921388 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136924 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20+,23?/m1/s1 JNTHBMXTLMHJGI-RIBUYDGZSA-N 536227 (2S)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.1::US11242344, Example 130.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536227&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572518 464921388 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136925 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccc(=O)n1C)c1cc(C)no1 InChI=1S/C29H33N5O5/c1-16(2)25(23-13-17(3)32-39-23)27(37)34-15-20(35)14-22(34)26-30-28(38)29(4,31-26)19-11-9-18(10-12-19)21-7-6-8-24(36)33(21)5/h6-13,16,20,22,25,35H,14-15H2,1-5H3,(H,30,31,38)/t20-,22-,25?,29-/m1/s1 NVXRTBAQPIGSRM-XEDDWCKHSA-N 536230 US11242344, Example 108.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536230&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407788 464921390 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136926 CC(C)C(C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@](C)(N1)c1ccc(cc1)-c1cccc(=O)n1C)c1cc(C)no1 InChI=1S/C29H33N5O5/c1-16(2)25(23-13-17(3)32-39-23)27(37)34-15-20(35)14-22(34)26-30-28(38)29(4,31-26)19-11-9-18(10-12-19)21-7-6-8-24(36)33(21)5/h6-13,16,20,22,25,35H,14-15H2,1-5H3,(H,30,31,38)/t20-,22-,25?,29-/m1/s1 NVXRTBAQPIGSRM-XEDDWCKHSA-N 536230 US11242344, Example 108.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >300 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536230&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407788 464921390 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136927 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20-,23?/m1/s1 JNTHBMXTLMHJGI-IDXKXCSNSA-N 536231 (2R)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.3::US11242344, Example 130.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 17600 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536231&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 158970513 464921391 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136928 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20-,23?/m1/s1 JNTHBMXTLMHJGI-IDXKXCSNSA-N 536231 (2R)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.3::US11242344, Example 130.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 4690 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536231&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 158970513 464921391 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136929 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20-,23?/m1/s1 JNTHBMXTLMHJGI-IDXKXCSNSA-N 536231 (2R)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.3::US11242344, Example 130.4 von Hippel-Lindau disease tumor suppressor Human 16200 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536231&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 158970513 464921391 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136930 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21+,22-,27+/m1/s1 HAPGPSOTLKJYEI-RYBWSMFQSA-N 536232 (5S)-2-((4R)-4-Hydroxy-1-(3-methyl-2-(1-methyl-1H-pyrazol-4-yl) butanoyl) pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl) phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 110.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 20600 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536232&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572709 464921392 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136931 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21+,22-,27+/m1/s1 HAPGPSOTLKJYEI-RYBWSMFQSA-N 536232 (5S)-2-((4R)-4-Hydroxy-1-(3-methyl-2-(1-methyl-1H-pyrazol-4-yl) butanoyl) pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl) phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 110.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 7420 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536232&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572709 464921392 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136932 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21+,22-,27+/m1/s1 HAPGPSOTLKJYEI-RYBWSMFQSA-N 536232 (5S)-2-((4R)-4-Hydroxy-1-(3-methyl-2-(1-methyl-1H-pyrazol-4-yl) butanoyl) pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl) phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 110.1 von Hippel-Lindau disease tumor suppressor Human 28100 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536232&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572709 464921392 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136933 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20-,23?/m1/s1 JNTHBMXTLMHJGI-IDXKXCSNSA-N 536231 (2R)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.3::US11242344, Example 130.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 17500 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536231&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 158970513 464921391 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136934 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20-,23?/m1/s1 JNTHBMXTLMHJGI-IDXKXCSNSA-N 536231 (2R)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.3::US11242344, Example 130.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 4240 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536231&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 158970513 464921391 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136935 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC2(CCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C23H28N4O4/c1-13(2)20(19-10-14(3)25-30-19)22(29)27-12-16(28)11-18(27)21-24-23(31-26-21)9-8-15-6-4-5-7-17(15)23/h4-7,10,13,16,18,20,28H,8-9,11-12H2,1-3H3,(H,24,26)/t16-,18+,20-,23?/m1/s1 JNTHBMXTLMHJGI-IDXKXCSNSA-N 536231 (2R)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 130.3::US11242344, Example 130.4 von Hippel-Lindau disease tumor suppressor Human 34500 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536231&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 158970513 464921391 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136936 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21-,22-,27+/m1/s1 HAPGPSOTLKJYEI-RKGZYEPBSA-N 536234 US11242344, Example 110.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536234&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572491 464921393 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136937 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21-,22-,27+/m1/s1 HAPGPSOTLKJYEI-RKGZYEPBSA-N 536234 US11242344, Example 110.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 104000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536234&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572491 464921393 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136938 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21-,22-,27+/m1/s1 HAPGPSOTLKJYEI-RKGZYEPBSA-N 536234 US11242344, Example 110.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536234&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572491 464921393 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136939 CC(C)[C@H](C(=O)N1C[C@H](O)CC1C1=NOC2(CCCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C24H30N4O4/c1-14(2)21(20-11-15(3)26-31-20)23(30)28-13-17(29)12-19(28)22-25-24(32-27-22)10-6-8-16-7-4-5-9-18(16)24/h4-5,7,9,11,14,17,19,21,29H,6,8,10,12-13H2,1-3H3,(H,25,27)/t17-,19?,21+,24?/m1/s1 DYVCCEQFPYNQOG-APZJKXHZSA-N 536235 (2S)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthalene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 131.1::US11242344, Example 131.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 160000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536235&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572669 464921394 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136940 CC(C)[C@H](C(=O)N1C[C@H](O)CC1C1=NOC2(CCCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C24H30N4O4/c1-14(2)21(20-11-15(3)26-31-20)23(30)28-13-17(29)12-19(28)22-25-24(32-27-22)10-6-8-16-7-4-5-9-18(16)24/h4-5,7,9,11,14,17,19,21,29H,6,8,10,12-13H2,1-3H3,(H,25,27)/t17-,19?,21+,24?/m1/s1 DYVCCEQFPYNQOG-APZJKXHZSA-N 536235 (2S)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthalene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 131.1::US11242344, Example 131.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536235&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572669 464921394 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136941 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21+,22+,27+/m1/s1 HAPGPSOTLKJYEI-HLIRBWCUSA-N 536236 US11242344, Example 110.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536236&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572831 464921395 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136942 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21+,22+,27+/m1/s1 HAPGPSOTLKJYEI-HLIRBWCUSA-N 536236 US11242344, Example 110.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536236&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572831 464921395 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136943 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21+,22+,27+/m1/s1 HAPGPSOTLKJYEI-HLIRBWCUSA-N 536236 US11242344, Example 110.3 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536236&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572831 464921395 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136944 CC(C)[C@H](C(=O)N1C[C@H](O)CC1C1=NOC2(CCCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C24H30N4O4/c1-14(2)21(20-11-15(3)26-31-20)23(30)28-13-17(29)12-19(28)22-25-24(32-27-22)10-6-8-16-7-4-5-9-18(16)24/h4-5,7,9,11,14,17,19,21,29H,6,8,10,12-13H2,1-3H3,(H,25,27)/t17-,19?,21+,24?/m1/s1 DYVCCEQFPYNQOG-APZJKXHZSA-N 536235 (2S)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthalene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 131.1::US11242344, Example 131.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 242000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536235&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572669 464921394 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136945 CC(C)[C@H](C(=O)N1C[C@H](O)CC1C1=NOC2(CCCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C24H30N4O4/c1-14(2)21(20-11-15(3)26-31-20)23(30)28-13-17(29)12-19(28)22-25-24(32-27-22)10-6-8-16-7-4-5-9-18(16)24/h4-5,7,9,11,14,17,19,21,29H,6,8,10,12-13H2,1-3H3,(H,25,27)/t17-,19?,21+,24?/m1/s1 DYVCCEQFPYNQOG-APZJKXHZSA-N 536235 (2S)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthalene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 131.1::US11242344, Example 131.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536235&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572669 464921394 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136946 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21-,22+,27+/m1/s1 HAPGPSOTLKJYEI-YHZQYDDPSA-N 536238 US11242344, Example 110.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536238&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572869 464921396 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136947 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21-,22+,27+/m1/s1 HAPGPSOTLKJYEI-YHZQYDDPSA-N 536238 US11242344, Example 110.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536238&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572869 464921396 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136948 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cnn(C)c1 InChI=1S/C27H32N6O3S/c1-15(2)22(18-11-29-32(5)12-18)25(35)33-13-20(34)10-21(33)24-30-26(36)27(4,31-24)19-8-6-17(7-9-19)23-16(3)28-14-37-23/h6-9,11-12,14-15,20-22,34H,10,13H2,1-5H3,(H,30,31,36)/t20-,21-,22+,27+/m1/s1 HAPGPSOTLKJYEI-YHZQYDDPSA-N 536238 US11242344, Example 110.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536238&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572869 464921396 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136949 CC(C)[C@@H](C(=O)N1C[C@H](O)CC1C1=NOC2(CCCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C24H30N4O4/c1-14(2)21(20-11-15(3)26-31-20)23(30)28-13-17(29)12-19(28)22-25-24(32-27-22)10-6-8-16-7-4-5-9-18(16)24/h4-5,7,9,11,14,17,19,21,29H,6,8,10,12-13H2,1-3H3,(H,25,27)/t17-,19?,21-,24?/m1/s1 DYVCCEQFPYNQOG-PJXQYFAUSA-N 536239 (2R)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthalene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 131.3::US11242344, Example 131.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 19600 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536239&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 147455118 464921397 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136950 CC(C)[C@@H](C(=O)N1C[C@H](O)CC1C1=NOC2(CCCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C24H30N4O4/c1-14(2)21(20-11-15(3)26-31-20)23(30)28-13-17(29)12-19(28)22-25-24(32-27-22)10-6-8-16-7-4-5-9-18(16)24/h4-5,7,9,11,14,17,19,21,29H,6,8,10,12-13H2,1-3H3,(H,25,27)/t17-,19?,21-,24?/m1/s1 DYVCCEQFPYNQOG-PJXQYFAUSA-N 536239 (2R)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthalene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 131.3::US11242344, Example 131.4 von Hippel-Lindau disease tumor suppressor Human 23000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536239&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 147455118 464921397 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136951 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C InChI=1S/C29H39N5O5S/c1-16-21(40-15-30-16)17-9-11-18(12-10-17)29(8)25(37)32-23(33-29)20-13-19(35)14-34(20)24(36)22(27(2,3)4)31-26(38)39-28(5,6)7/h9-12,15,19-20,22,35H,13-14H2,1-8H3,(H,31,38)(H,32,33,37)/t19-,20?,22-,29+/m1/s1 JJXYWQAUBWYEIW-OMFJFRDPSA-N 536240 1-Cyano-N-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)cyclopropane-1-carboxamide (2 Single Stereoisomers)::US11242344, Example 111.1::US11242344, Example 111.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 111000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536240&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572544 464921398 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136952 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C InChI=1S/C29H39N5O5S/c1-16-21(40-15-30-16)17-9-11-18(12-10-17)29(8)25(37)32-23(33-29)20-13-19(35)14-34(20)24(36)22(27(2,3)4)31-26(38)39-28(5,6)7/h9-12,15,19-20,22,35H,13-14H2,1-8H3,(H,31,38)(H,32,33,37)/t19-,20?,22-,29+/m1/s1 JJXYWQAUBWYEIW-OMFJFRDPSA-N 536240 1-Cyano-N-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)cyclopropane-1-carboxamide (2 Single Stereoisomers)::US11242344, Example 111.1::US11242344, Example 111.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 31800 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536240&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572544 464921398 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136953 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C InChI=1S/C29H39N5O5S/c1-16-21(40-15-30-16)17-9-11-18(12-10-17)29(8)25(37)32-23(33-29)20-13-19(35)14-34(20)24(36)22(27(2,3)4)31-26(38)39-28(5,6)7/h9-12,15,19-20,22,35H,13-14H2,1-8H3,(H,31,38)(H,32,33,37)/t19-,20?,22-,29+/m1/s1 JJXYWQAUBWYEIW-OMFJFRDPSA-N 536240 1-Cyano-N-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)cyclopropane-1-carboxamide (2 Single Stereoisomers)::US11242344, Example 111.1::US11242344, Example 111.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536240&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572544 464921398 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136954 CC(C)[C@@H](C(=O)N1C[C@H](O)CC1C1=NOC2(CCCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C24H30N4O4/c1-14(2)21(20-11-15(3)26-31-20)23(30)28-13-17(29)12-19(28)22-25-24(32-27-22)10-6-8-16-7-4-5-9-18(16)24/h4-5,7,9,11,14,17,19,21,29H,6,8,10,12-13H2,1-3H3,(H,25,27)/t17-,19?,21-,24?/m1/s1 DYVCCEQFPYNQOG-PJXQYFAUSA-N 536239 (2R)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthalene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 131.3::US11242344, Example 131.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 19900 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536239&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 147455118 464921397 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136955 CC(C)[C@@H](C(=O)N1C[C@H](O)CC1C1=NOC2(CCCc3ccccc23)N1)c1cc(C)no1 InChI=1S/C24H30N4O4/c1-14(2)21(20-11-15(3)26-31-20)23(30)28-13-17(29)12-19(28)22-25-24(32-27-22)10-6-8-16-7-4-5-9-18(16)24/h4-5,7,9,11,14,17,19,21,29H,6,8,10,12-13H2,1-3H3,(H,25,27)/t17-,19?,21-,24?/m1/s1 DYVCCEQFPYNQOG-PJXQYFAUSA-N 536239 (2R)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthalene-1,5'-[1,2,4]oxadiazol]-3'-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 131.3::US11242344, Example 131.4 von Hippel-Lindau disease tumor suppressor Human 20000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536239&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 147455118 464921397 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136956 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C InChI=1S/C29H39N5O5S/c1-16-21(40-15-30-16)17-9-11-18(12-10-17)29(8)25(37)32-23(33-29)20-13-19(35)14-34(20)24(36)22(27(2,3)4)31-26(38)39-28(5,6)7/h9-12,15,19-20,22,35H,13-14H2,1-8H3,(H,31,38)(H,32,33,37)/t19-,20?,22-,29+/m1/s1 JJXYWQAUBWYEIW-OMFJFRDPSA-N 536240 1-Cyano-N-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)cyclopropane-1-carboxamide (2 Single Stereoisomers)::US11242344, Example 111.1::US11242344, Example 111.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 4970 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536240&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572544 464921398 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136957 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C InChI=1S/C29H39N5O5S/c1-16-21(40-15-30-16)17-9-11-18(12-10-17)29(8)25(37)32-23(33-29)20-13-19(35)14-34(20)24(36)22(27(2,3)4)31-26(38)39-28(5,6)7/h9-12,15,19-20,22,35H,13-14H2,1-8H3,(H,31,38)(H,32,33,37)/t19-,20?,22-,29+/m1/s1 JJXYWQAUBWYEIW-OMFJFRDPSA-N 536240 1-Cyano-N-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)cyclopropane-1-carboxamide (2 Single Stereoisomers)::US11242344, Example 111.1::US11242344, Example 111.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 1860 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536240&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572544 464921398 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136958 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C InChI=1S/C29H39N5O5S/c1-16-21(40-15-30-16)17-9-11-18(12-10-17)29(8)25(37)32-23(33-29)20-13-19(35)14-34(20)24(36)22(27(2,3)4)31-26(38)39-28(5,6)7/h9-12,15,19-20,22,35H,13-14H2,1-8H3,(H,31,38)(H,32,33,37)/t19-,20?,22-,29+/m1/s1 JJXYWQAUBWYEIW-OMFJFRDPSA-N 536240 1-Cyano-N-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)cyclopropane-1-carboxamide (2 Single Stereoisomers)::US11242344, Example 111.1::US11242344, Example 111.2 von Hippel-Lindau disease tumor suppressor Human 5110 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536240&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572544 464921398 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136959 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccccc1)c1ccccc1)c1cc(C)no1 InChI=1/C27H30N4O4/c1-17(2)24(23-14-18(3)29-34-23)26(33)31-16-21(32)15-22(31)25-28-27(35-30-25,19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-14,17,21-22,24,32H,15-16H2,1-3H3,(H,28,30)/t21-,22+,24+/s2 QLVWODLSBTTWFS-GPXNEJASSA-N 536243 (S)-1-((2S,4R)-2-(5,5-diphenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 132.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Homo sapiens 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536243&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572414 464921399 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 8QVU,8QU8,4B9K,4WQO,9IPW,9EQM,9EQJ,8ZVJ,8ZV8,8QW7,8QW6,8QJS,8QJR,8PC2,8P0F,8G1Q,8G1P,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,8BB5,8BB4,8BB3,8BB2,7ZNT,7Z77,7Z76,7Z6L,7S4E,7JTP,7JTO,6SIS,6HAY,6HAX,6GMX,6GMQ,6GMN,6GFZ,6GFY,6BVB,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5LLI,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B95,3ZTD,1LQB,8EI3,6GMR,4AWJ,4AJY,3ZUN,3ZTC,3ZRF,3ZRC,8FY2,8FY1,8FY0,9QE5,9QE4,7Q2J,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,8YMB,9BOL,9BJU,7CJB,8VLB,8VL9,8EWV,7KHH,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,1HV2 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 8BB5,8BB4,8BB3,8BB2,6I7Q,8RWZ,8FY0,8JE2,8JE1,8IJ1,9QE5,9QE4,9IPW,9EQM,9EQJ,8ZVJ,8ZV8,8QW7,8QW6,8QVU,8QJS,8QJR,8PC2,8P0F,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,7ZNT,7ZLS,7ZLR,7ZLP,7ZLO,7ZLN,7ZLM,7Z77,7Z76,7Z6L,7Q2J,7JTP,7JTO,6V9H,6SIS,6I5N,6I5J,6I4X,6HR2,6HAY,6HAX,6GMX,6GMR,6GMQ,6GMN,6GFZ,6GFY,6GFX,6FMK,6FMJ,6FMI,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5N4W,5LLI,5BO4,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B9K,4B95,4AWJ,4AJY,3ZUN,3ZTD,3ZTC,3ZRF,3ZRC,3ZNG,3DCG,2IZV,2C9W,9OMF,9OMA,9LKY,9LAF,9J79,9J78,9J77,9GIO,9BOL,9BJU,8Y1U,8WQH,8WQG,8WQF,8WQE,8WQC,8WQB,8WQA,8WDK,8VLB,8VL9,8SZK,8SH2,8RX0,8JAV,8JAU,8JAS,8JAR,8JAQ,8G1Q,8FY2,8FY1,8EWV,8EI3,7UPN,7S4E,7PI4,7M6T,7KHH,6ZHC,6C5X,6BVB,4WQO,4N9F,3ZKJ,2JZ3,2FNJ,1LQB,1LM8,8YMB,6I7R,7CJB,8EBN,9D1Y,9D1I,9D1Z,9D8P,8R5H,8Q7R,8PQL,8OL1,8OKX,8OF0,8OEW,8OEV,8JAL,8G1P,8CX2,8CX1,8CX0,8C13,7SHL,7SHK,7PLO,6R7N,6R7H,6R7F,6P59,1VCB,8QU8,2MA9 Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 9OMF,9OMA,9LKY,9D8P,8WQH,8WQG,8WQF,8WQE,8WQC,8WQB,8WQA,8VLB,8VL9,8SZK,8R5H,8Q7R,8PQL,8OL1,8OKX,8OF0,8OEW,8OEV,8JAV,8JAU,8JAS,8JAR,8JAQ,8JAL,8G1P,8FY2,8FY1,8FY0,8EWV,8EI3,8CX2,8CX1,8CX0,8C13,7ZLS,7ZLR,7ZLP,7ZLO,7ZLN,7ZLM,7UPN,7PLO,7M6T,7KHH,6V9H,6R7F,6P59,6I7R,6I7Q,6GMR,6C5X,6BVB,4WQO,4B95,4AJY,3ZUN,3ZTD,3ZTC,3ZRF,3ZRC,3ZNG,3ZKJ,3DCG,2MA9,2JZ3,2IZV,2C9W,1VCB,1LQB,1LM8,8YMB,9J79,9J78,9J77,8QU8,6ZHC,6R7I,7PI4,9QE5,9QE4,6R6H,9LAF,9IPW,9EQM,9EQJ,9D1Z,9D1Y,9D1I,9BOL,9BJU,8ZVJ,8ZV8,8Y1U,8WDK,8SH2,8RX0,8RWZ,8QW7,8QW6,8QVU,8QJS,8QJR,8PC2,8P0F,8JE2,8JE1,8IJ1,8G1Q,8EBN,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,8BB5,8BB4,8BB3,8BB2,7ZNT,7Z77,7Z76,7Z6L,7S4E,7Q2J,7JTP,7JTO,6SIS,6R7N,6R7H,6I5N,6I5J,6I4X,6HR2,6HAY,6HAX,6GMX,6GMQ,6GMN,6GFZ,6GFY,6GFX,6FMK,6FMJ,6FMI,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5N4W,5LLI,5BO4,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B9K,4AWJ,9GIO,4N9F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136960 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccccc1)c1ccccc1)c1cc(C)no1 536243 (S)-1-((2S,4R)-2-(5,5-diphenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 132.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Homo sapiens 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536243&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572414 464921399 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 8QVU,8QU8,4B9K,4WQO,9IPW,9EQM,9EQJ,8ZVJ,8ZV8,8QW7,8QW6,8QJS,8QJR,8PC2,8P0F,8G1Q,8G1P,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,8BB5,8BB4,8BB3,8BB2,7ZNT,7Z77,7Z76,7Z6L,7S4E,7JTP,7JTO,6SIS,6HAY,6HAX,6GMX,6GMQ,6GMN,6GFZ,6GFY,6BVB,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5LLI,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B95,3ZTD,1LQB,8EI3,6GMR,4AWJ,4AJY,3ZUN,3ZTC,3ZRF,3ZRC,8FY2,8FY1,8FY0,9QE5,9QE4,7Q2J,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,8YMB,9BOL,9BJU,7CJB,8VLB,8VL9,8EWV,7KHH,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,1HV2 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 8BB5,8BB4,8BB3,8BB2,6I7Q,8RWZ,8FY0,8JE2,8JE1,8IJ1,9QE5,9QE4,9IPW,9EQM,9EQJ,8ZVJ,8ZV8,8QW7,8QW6,8QVU,8QJS,8QJR,8PC2,8P0F,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,7ZNT,7ZLS,7ZLR,7ZLP,7ZLO,7ZLN,7ZLM,7Z77,7Z76,7Z6L,7Q2J,7JTP,7JTO,6V9H,6SIS,6I5N,6I5J,6I4X,6HR2,6HAY,6HAX,6GMX,6GMR,6GMQ,6GMN,6GFZ,6GFY,6GFX,6FMK,6FMJ,6FMI,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5N4W,5LLI,5BO4,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B9K,4B95,4AWJ,4AJY,3ZUN,3ZTD,3ZTC,3ZRF,3ZRC,3ZNG,3DCG,2IZV,2C9W,9OMF,9OMA,9LKY,9LAF,9J79,9J78,9J77,9GIO,9BOL,9BJU,8Y1U,8WQH,8WQG,8WQF,8WQE,8WQC,8WQB,8WQA,8WDK,8VLB,8VL9,8SZK,8SH2,8RX0,8JAV,8JAU,8JAS,8JAR,8JAQ,8G1Q,8FY2,8FY1,8EWV,8EI3,7UPN,7S4E,7PI4,7M6T,7KHH,6ZHC,6C5X,6BVB,4WQO,4N9F,3ZKJ,2JZ3,2FNJ,1LQB,1LM8,8YMB,6I7R,7CJB,8EBN,9D1Y,9D1I,9D1Z,9D8P,8R5H,8Q7R,8PQL,8OL1,8OKX,8OF0,8OEW,8OEV,8JAL,8G1P,8CX2,8CX1,8CX0,8C13,7SHL,7SHK,7PLO,6R7N,6R7H,6R7F,6P59,1VCB,8QU8,2MA9 Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 9OMF,9OMA,9LKY,9D8P,8WQH,8WQG,8WQF,8WQE,8WQC,8WQB,8WQA,8VLB,8VL9,8SZK,8R5H,8Q7R,8PQL,8OL1,8OKX,8OF0,8OEW,8OEV,8JAV,8JAU,8JAS,8JAR,8JAQ,8JAL,8G1P,8FY2,8FY1,8FY0,8EWV,8EI3,8CX2,8CX1,8CX0,8C13,7ZLS,7ZLR,7ZLP,7ZLO,7ZLN,7ZLM,7UPN,7PLO,7M6T,7KHH,6V9H,6R7F,6P59,6I7R,6I7Q,6GMR,6C5X,6BVB,4WQO,4B95,4AJY,3ZUN,3ZTD,3ZTC,3ZRF,3ZRC,3ZNG,3ZKJ,3DCG,2MA9,2JZ3,2IZV,2C9W,1VCB,1LQB,1LM8,8YMB,9J79,9J78,9J77,8QU8,6ZHC,6R7I,7PI4,9QE5,9QE4,6R6H,9LAF,9IPW,9EQM,9EQJ,9D1Z,9D1Y,9D1I,9BOL,9BJU,8ZVJ,8ZV8,8Y1U,8WDK,8SH2,8RX0,8RWZ,8QW7,8QW6,8QVU,8QJS,8QJR,8PC2,8P0F,8JE2,8JE1,8IJ1,8G1Q,8EBN,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,8BB5,8BB4,8BB3,8BB2,7ZNT,7Z77,7Z76,7Z6L,7S4E,7Q2J,7JTP,7JTO,6SIS,6R7N,6R7H,6I5N,6I5J,6I4X,6HR2,6HAY,6HAX,6GMX,6GMQ,6GMN,6GFZ,6GFY,6GFX,6FMK,6FMJ,6FMI,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5N4W,5LLI,5BO4,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B9K,4AWJ,9GIO,4N9F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136961 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccccc1)c1ccccc1)c1cc(C)no1 536243 (S)-1-((2S,4R)-2-(5,5-diphenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 132.1 von Hippel-Lindau disease tumor suppressor Homo sapiens 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536243&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572414 464921399 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 4WQO,8QVU,8QU8,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,1HV2 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136962 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1S(C)(=O)=O InChI=1S/C24H29N5O5S2/c1-14-20(35-13-25-14)15-6-8-16(9-7-15)24(2)23(32)26-21(27-24)19-11-17(30)12-28(19)22(31)18-5-4-10-29(18)36(3,33)34/h6-9,13,17-19,30H,4-5,10-12H2,1-3H3,(H,26,27,32)/t17-,18+,19?,24+/m1/s1 JMHDAGHLLTXOHA-CAQGRGCHSA-N 536244 (5S)-2-((4R)-4-hydroxy-1-((methylsulfonyl)-L-prolyl) pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl) phenyl)-1,5-dihydro-4H-imidazol-4-one (2 Single Stereoisomers)::US11242344, Example 112.1::US11242344, Example 112.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 23300 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536244&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572333 464921400 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136963 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1S(C)(=O)=O InChI=1S/C24H29N5O5S2/c1-14-20(35-13-25-14)15-6-8-16(9-7-15)24(2)23(32)26-21(27-24)19-11-17(30)12-28(19)22(31)18-5-4-10-29(18)36(3,33)34/h6-9,13,17-19,30H,4-5,10-12H2,1-3H3,(H,26,27,32)/t17-,18+,19?,24+/m1/s1 JMHDAGHLLTXOHA-CAQGRGCHSA-N 536244 (5S)-2-((4R)-4-hydroxy-1-((methylsulfonyl)-L-prolyl) pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl) phenyl)-1,5-dihydro-4H-imidazol-4-one (2 Single Stereoisomers)::US11242344, Example 112.1::US11242344, Example 112.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 12100 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536244&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572333 464921400 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136964 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1S(C)(=O)=O InChI=1S/C24H29N5O5S2/c1-14-20(35-13-25-14)15-6-8-16(9-7-15)24(2)23(32)26-21(27-24)19-11-17(30)12-28(19)22(31)18-5-4-10-29(18)36(3,33)34/h6-9,13,17-19,30H,4-5,10-12H2,1-3H3,(H,26,27,32)/t17-,18+,19?,24+/m1/s1 JMHDAGHLLTXOHA-CAQGRGCHSA-N 536244 (5S)-2-((4R)-4-hydroxy-1-((methylsulfonyl)-L-prolyl) pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl) phenyl)-1,5-dihydro-4H-imidazol-4-one (2 Single Stereoisomers)::US11242344, Example 112.1::US11242344, Example 112.2 von Hippel-Lindau disease tumor suppressor Human 66400 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536244&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572333 464921400 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136965 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccccc1)c1ccccc1)c1cc(C)no1 InChI=1/C27H30N4O4/c1-17(2)24(23-14-18(3)29-34-23)26(33)31-16-21(32)15-22(31)25-28-27(35-30-25,19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-14,17,21-22,24,32H,15-16H2,1-3H3,(H,28,30)/t21-,22+,24-/s2 QLVWODLSBTTWFS-AOHZBQACSA-N 536245 (R)-1-((2S,4R)-2-(5,5-diphenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 132.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Homo sapiens 45700 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536245&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160453282 464921401 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 8QVU,8QU8,4B9K,4WQO,9IPW,9EQM,9EQJ,8ZVJ,8ZV8,8QW7,8QW6,8QJS,8QJR,8PC2,8P0F,8G1Q,8G1P,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,8BB5,8BB4,8BB3,8BB2,7ZNT,7Z77,7Z76,7Z6L,7S4E,7JTP,7JTO,6SIS,6HAY,6HAX,6GMX,6GMQ,6GMN,6GFZ,6GFY,6BVB,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5LLI,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B95,3ZTD,1LQB,8EI3,6GMR,4AWJ,4AJY,3ZUN,3ZTC,3ZRF,3ZRC,8FY2,8FY1,8FY0,9QE5,9QE4,7Q2J,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,8YMB,9BOL,9BJU,7CJB,8VLB,8VL9,8EWV,7KHH,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,1HV2 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 8BB5,8BB4,8BB3,8BB2,6I7Q,8RWZ,8FY0,8JE2,8JE1,8IJ1,9QE5,9QE4,9IPW,9EQM,9EQJ,8ZVJ,8ZV8,8QW7,8QW6,8QVU,8QJS,8QJR,8PC2,8P0F,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,7ZNT,7ZLS,7ZLR,7ZLP,7ZLO,7ZLN,7ZLM,7Z77,7Z76,7Z6L,7Q2J,7JTP,7JTO,6V9H,6SIS,6I5N,6I5J,6I4X,6HR2,6HAY,6HAX,6GMX,6GMR,6GMQ,6GMN,6GFZ,6GFY,6GFX,6FMK,6FMJ,6FMI,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5N4W,5LLI,5BO4,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B9K,4B95,4AWJ,4AJY,3ZUN,3ZTD,3ZTC,3ZRF,3ZRC,3ZNG,3DCG,2IZV,2C9W,9OMF,9OMA,9LKY,9LAF,9J79,9J78,9J77,9GIO,9BOL,9BJU,8Y1U,8WQH,8WQG,8WQF,8WQE,8WQC,8WQB,8WQA,8WDK,8VLB,8VL9,8SZK,8SH2,8RX0,8JAV,8JAU,8JAS,8JAR,8JAQ,8G1Q,8FY2,8FY1,8EWV,8EI3,7UPN,7S4E,7PI4,7M6T,7KHH,6ZHC,6C5X,6BVB,4WQO,4N9F,3ZKJ,2JZ3,2FNJ,1LQB,1LM8,8YMB,6I7R,7CJB,8EBN,9D1Y,9D1I,9D1Z,9D8P,8R5H,8Q7R,8PQL,8OL1,8OKX,8OF0,8OEW,8OEV,8JAL,8G1P,8CX2,8CX1,8CX0,8C13,7SHL,7SHK,7PLO,6R7N,6R7H,6R7F,6P59,1VCB,8QU8,2MA9 Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 9OMF,9OMA,9LKY,9D8P,8WQH,8WQG,8WQF,8WQE,8WQC,8WQB,8WQA,8VLB,8VL9,8SZK,8R5H,8Q7R,8PQL,8OL1,8OKX,8OF0,8OEW,8OEV,8JAV,8JAU,8JAS,8JAR,8JAQ,8JAL,8G1P,8FY2,8FY1,8FY0,8EWV,8EI3,8CX2,8CX1,8CX0,8C13,7ZLS,7ZLR,7ZLP,7ZLO,7ZLN,7ZLM,7UPN,7PLO,7M6T,7KHH,6V9H,6R7F,6P59,6I7R,6I7Q,6GMR,6C5X,6BVB,4WQO,4B95,4AJY,3ZUN,3ZTD,3ZTC,3ZRF,3ZRC,3ZNG,3ZKJ,3DCG,2MA9,2JZ3,2IZV,2C9W,1VCB,1LQB,1LM8,8YMB,9J79,9J78,9J77,8QU8,6ZHC,6R7I,7PI4,9QE5,9QE4,6R6H,9LAF,9IPW,9EQM,9EQJ,9D1Z,9D1Y,9D1I,9BOL,9BJU,8ZVJ,8ZV8,8Y1U,8WDK,8SH2,8RX0,8RWZ,8QW7,8QW6,8QVU,8QJS,8QJR,8PC2,8P0F,8JE2,8JE1,8IJ1,8G1Q,8EBN,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,8BB5,8BB4,8BB3,8BB2,7ZNT,7Z77,7Z76,7Z6L,7S4E,7Q2J,7JTP,7JTO,6SIS,6R7N,6R7H,6I5N,6I5J,6I4X,6HR2,6HAY,6HAX,6GMX,6GMQ,6GMN,6GFZ,6GFY,6GFX,6FMK,6FMJ,6FMI,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5N4W,5LLI,5BO4,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B9K,4AWJ,9GIO,4N9F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136966 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccccc1)c1ccccc1)c1cc(C)no1 536245 (R)-1-((2S,4R)-2-(5,5-diphenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 132.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Homo sapiens 12600 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536245&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160453282 464921401 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 8QVU,8QU8,4B9K,4WQO,9IPW,9EQM,9EQJ,8ZVJ,8ZV8,8QW7,8QW6,8QJS,8QJR,8PC2,8P0F,8G1Q,8G1P,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,8BB5,8BB4,8BB3,8BB2,7ZNT,7Z77,7Z76,7Z6L,7S4E,7JTP,7JTO,6SIS,6HAY,6HAX,6GMX,6GMQ,6GMN,6GFZ,6GFY,6BVB,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5LLI,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B95,3ZTD,1LQB,8EI3,6GMR,4AWJ,4AJY,3ZUN,3ZTC,3ZRF,3ZRC,8FY2,8FY1,8FY0,9QE5,9QE4,7Q2J,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,8YMB,9BOL,9BJU,7CJB,8VLB,8VL9,8EWV,7KHH,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,1HV2 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 8BB5,8BB4,8BB3,8BB2,6I7Q,8RWZ,8FY0,8JE2,8JE1,8IJ1,9QE5,9QE4,9IPW,9EQM,9EQJ,8ZVJ,8ZV8,8QW7,8QW6,8QVU,8QJS,8QJR,8PC2,8P0F,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,7ZNT,7ZLS,7ZLR,7ZLP,7ZLO,7ZLN,7ZLM,7Z77,7Z76,7Z6L,7Q2J,7JTP,7JTO,6V9H,6SIS,6I5N,6I5J,6I4X,6HR2,6HAY,6HAX,6GMX,6GMR,6GMQ,6GMN,6GFZ,6GFY,6GFX,6FMK,6FMJ,6FMI,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5N4W,5LLI,5BO4,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B9K,4B95,4AWJ,4AJY,3ZUN,3ZTD,3ZTC,3ZRF,3ZRC,3ZNG,3DCG,2IZV,2C9W,9OMF,9OMA,9LKY,9LAF,9J79,9J78,9J77,9GIO,9BOL,9BJU,8Y1U,8WQH,8WQG,8WQF,8WQE,8WQC,8WQB,8WQA,8WDK,8VLB,8VL9,8SZK,8SH2,8RX0,8JAV,8JAU,8JAS,8JAR,8JAQ,8G1Q,8FY2,8FY1,8EWV,8EI3,7UPN,7S4E,7PI4,7M6T,7KHH,6ZHC,6C5X,6BVB,4WQO,4N9F,3ZKJ,2JZ3,2FNJ,1LQB,1LM8,8YMB,6I7R,7CJB,8EBN,9D1Y,9D1I,9D1Z,9D8P,8R5H,8Q7R,8PQL,8OL1,8OKX,8OF0,8OEW,8OEV,8JAL,8G1P,8CX2,8CX1,8CX0,8C13,7SHL,7SHK,7PLO,6R7N,6R7H,6R7F,6P59,1VCB,8QU8,2MA9 Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 9OMF,9OMA,9LKY,9D8P,8WQH,8WQG,8WQF,8WQE,8WQC,8WQB,8WQA,8VLB,8VL9,8SZK,8R5H,8Q7R,8PQL,8OL1,8OKX,8OF0,8OEW,8OEV,8JAV,8JAU,8JAS,8JAR,8JAQ,8JAL,8G1P,8FY2,8FY1,8FY0,8EWV,8EI3,8CX2,8CX1,8CX0,8C13,7ZLS,7ZLR,7ZLP,7ZLO,7ZLN,7ZLM,7UPN,7PLO,7M6T,7KHH,6V9H,6R7F,6P59,6I7R,6I7Q,6GMR,6C5X,6BVB,4WQO,4B95,4AJY,3ZUN,3ZTD,3ZTC,3ZRF,3ZRC,3ZNG,3ZKJ,3DCG,2MA9,2JZ3,2IZV,2C9W,1VCB,1LQB,1LM8,8YMB,9J79,9J78,9J77,8QU8,6ZHC,6R7I,7PI4,9QE5,9QE4,6R6H,9LAF,9IPW,9EQM,9EQJ,9D1Z,9D1Y,9D1I,9BOL,9BJU,8ZVJ,8ZV8,8Y1U,8WDK,8SH2,8RX0,8RWZ,8QW7,8QW6,8QVU,8QJS,8QJR,8PC2,8P0F,8JE2,8JE1,8IJ1,8G1Q,8EBN,8CQL,8CQK,8CQE,8BEB,8BDX,8BDT,8BDS,8BDO,8BDN,8BDM,8BDL,8BDJ,8BDI,8BB5,8BB4,8BB3,8BB2,7ZNT,7Z77,7Z76,7Z6L,7S4E,7Q2J,7JTP,7JTO,6SIS,6R7N,6R7H,6I5N,6I5J,6I4X,6HR2,6HAY,6HAX,6GMX,6GMQ,6GMN,6GFZ,6GFY,6GFX,6FMK,6FMJ,6FMI,5T35,5NW2,5NW1,5NW0,5NVZ,5NVY,5NVX,5NVW,5NVV,5N4W,5LLI,5BO4,4W9L,4W9K,4W9J,4W9I,4W9H,4W9G,4W9F,4W9E,4W9D,4W9C,4BKT,4BKS,4B9K,4AWJ,9GIO,4N9F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136967 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccccc1)c1ccccc1)c1cc(C)no1 536245 (R)-1-((2S,4R)-2-(5,5-diphenyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 132.2 von Hippel-Lindau disease tumor suppressor Homo sapiens 39400 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536245&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 160453282 464921401 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 4WQO,8QVU,8QU8,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,1HV2 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136968 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)C1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1S(C)(=O)=O InChI=1S/C24H29N5O5S2/c1-14-20(35-13-25-14)15-6-8-16(9-7-15)24(2)23(32)26-21(27-24)19-11-17(30)12-28(19)22(31)18-5-4-10-29(18)36(3,33)34/h6-9,13,17-19,30H,4-5,10-12H2,1-3H3,(H,26,27,32)/t17-,18+,19?,24+/m1/s1 JMHDAGHLLTXOHA-CAQGRGCHSA-N 536244 (5S)-2-((4R)-4-hydroxy-1-((methylsulfonyl)-L-prolyl) pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl) phenyl)-1,5-dihydro-4H-imidazol-4-one (2 Single Stereoisomers)::US11242344, Example 112.1::US11242344, Example 112.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536244&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572333 464921400 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136969 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18+,21?/m1/s1 QYHDCFRWZLANQW-JFXSJQBISA-N 536247 (2S)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.1::US11242344, Example 133.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536247&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572680 464921402 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136970 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18+,21?/m1/s1 QYHDCFRWZLANQW-JFXSJQBISA-N 536247 (2S)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.1::US11242344, Example 133.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536247&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572680 464921402 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136971 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18+,21?/m1/s1 QYHDCFRWZLANQW-JFXSJQBISA-N 536247 (2S)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.1::US11242344, Example 133.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536247&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572680 464921402 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136972 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19+,22?/m1/s1 WEBARINGELPABF-OZICTILFSA-N 536248 (2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 113.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 70600 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536248&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572666 464921403 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136973 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19+,22?/m1/s1 WEBARINGELPABF-OZICTILFSA-N 536248 (2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 113.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 24100 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536248&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572666 464921403 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136974 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19+,22?/m1/s1 WEBARINGELPABF-OZICTILFSA-N 536248 (2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 113.1 von Hippel-Lindau disease tumor suppressor Human 96900 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536248&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572666 464921403 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136975 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18+,21?/m1/s1 QYHDCFRWZLANQW-JFXSJQBISA-N 536247 (2S)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.1::US11242344, Example 133.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536247&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572680 464921402 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136976 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18+,21?/m1/s1 QYHDCFRWZLANQW-JFXSJQBISA-N 536247 (2S)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.1::US11242344, Example 133.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536247&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572680 464921402 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136977 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18+,21?/m1/s1 QYHDCFRWZLANQW-JFXSJQBISA-N 536247 (2S)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.1::US11242344, Example 133.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536247&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572680 464921402 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136978 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19-,22+/m1/s1 WEBARINGELPABF-MNDCFMPDSA-N 536250 (2R)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 113.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 6300 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536250&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572705 464921404 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136979 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19-,22+/m1/s1 WEBARINGELPABF-MNDCFMPDSA-N 536250 (2R)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 113.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 2490 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536250&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572705 464921404 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136980 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19-,22+/m1/s1 WEBARINGELPABF-MNDCFMPDSA-N 536250 (2R)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 113.2 von Hippel-Lindau disease tumor suppressor Human 2940 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536250&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572705 464921404 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136981 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18-,21?/m1/s1 QYHDCFRWZLANQW-VVTKKKPISA-N 536251 (2R)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.3::US11242344, Example 133.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 34400 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536251&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160552760 464921405 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136982 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18-,21?/m1/s1 QYHDCFRWZLANQW-VVTKKKPISA-N 536251 (2R)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.3::US11242344, Example 133.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 36300 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536251&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160552760 464921405 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136983 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18-,21?/m1/s1 QYHDCFRWZLANQW-VVTKKKPISA-N 536251 (2R)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.3::US11242344, Example 133.4 von Hippel-Lindau disease tumor suppressor Human 22600 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536251&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 160552760 464921405 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136984 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19+,22-/m1/s1 WEBARINGELPABF-NIRMNWTQSA-N 536252 (2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::BDBM536273::US11242344, Example 113.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536252&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572784 464921406 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136985 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19+,22-/m1/s1 WEBARINGELPABF-NIRMNWTQSA-N 536252 (2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::BDBM536273::US11242344, Example 113.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 90800 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536252&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572784 464921406 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136986 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19+,22-/m1/s1 WEBARINGELPABF-NIRMNWTQSA-N 536252 (2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::BDBM536273::US11242344, Example 113.3 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536252&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572784 464921406 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136987 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18-,21?/m1/s1 QYHDCFRWZLANQW-VVTKKKPISA-N 536251 (2R)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.3::US11242344, Example 133.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 54900 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536251&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160552760 464921405 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136988 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18-,21?/m1/s1 QYHDCFRWZLANQW-VVTKKKPISA-N 536251 (2R)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.3::US11242344, Example 133.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 17400 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536251&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160552760 464921405 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136989 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NOC(N1)(c1ccc(Br)cc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H24BrF3N4O4/c1-11(2)18(17-8-12(3)28-33-17)20(32)30-10-15(31)9-16(30)19-27-21(34-29-19,22(24,25)26)13-4-6-14(23)7-5-13/h4-8,11,15-16,18,31H,9-10H2,1-3H3,(H,27,29)/t15-,16+,18-,21?/m1/s1 QYHDCFRWZLANQW-VVTKKKPISA-N 536251 (2R)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 133.3::US11242344, Example 133.4 von Hippel-Lindau disease tumor suppressor Human 52300 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536251&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 160552760 464921405 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136990 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19-,22-/m1/s1 WEBARINGELPABF-ZRAXVTTISA-N 536254 US11242344, Example 113.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 2280 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536254&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572634 464921407 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136991 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19-,22-/m1/s1 WEBARINGELPABF-ZRAXVTTISA-N 536254 US11242344, Example 113.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 3170 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536254&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572634 464921407 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136992 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19-,22-/m1/s1 WEBARINGELPABF-ZRAXVTTISA-N 536254 US11242344, Example 113.4 von Hippel-Lindau disease tumor suppressor Human 2920 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536254&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572634 464921407 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136993 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(CC(F)(F)F)C(C)(C)N1)c1cc(C)no1 InChI=1S/C19H28F3N5O3/c1-10(2)15(14-6-11(3)25-30-14)17(29)26-8-12(28)7-13(26)16-23-18(4,5)27(24-16)9-19(20,21)22/h6,10,12-13,15,28H,7-9H2,1-5H3,(H,23,24)/t12-,13+,15?/m1/s1 RMDQNUOGNKJAHB-NEJHNUGDSA-N 536255 1-((2S,4R)-2-(5,5-dimethyl-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 134.1::US11242344, Example 134.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536255&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160664859 464921408 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136994 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(CC(F)(F)F)C(C)(C)N1)c1cc(C)no1 InChI=1S/C19H28F3N5O3/c1-10(2)15(14-6-11(3)25-30-14)17(29)26-8-12(28)7-13(26)16-23-18(4,5)27(24-16)9-19(20,21)22/h6,10,12-13,15,28H,7-9H2,1-5H3,(H,23,24)/t12-,13+,15?/m1/s1 RMDQNUOGNKJAHB-NEJHNUGDSA-N 536255 1-((2S,4R)-2-(5,5-dimethyl-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 134.1::US11242344, Example 134.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536255&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160664859 464921408 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136995 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(CC(F)(F)F)C(C)(C)N1)c1cc(C)no1 InChI=1S/C19H28F3N5O3/c1-10(2)15(14-6-11(3)25-30-14)17(29)26-8-12(28)7-13(26)16-23-18(4,5)27(24-16)9-19(20,21)22/h6,10,12-13,15,28H,7-9H2,1-5H3,(H,23,24)/t12-,13+,15?/m1/s1 RMDQNUOGNKJAHB-NEJHNUGDSA-N 536255 1-((2S,4R)-2-(5,5-dimethyl-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 134.1::US11242344, Example 134.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536255&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 160664859 464921408 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136996 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21+/m1/s1 VNNBFHMSXBWONC-AWQBJMPUSA-N 536256 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.1::US11242344, Example 114.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536256&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572894 464921409 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136997 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21+/m1/s1 VNNBFHMSXBWONC-AWQBJMPUSA-N 536256 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.1::US11242344, Example 114.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536256&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572894 464921409 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1136998 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21+/m1/s1 VNNBFHMSXBWONC-AWQBJMPUSA-N 536256 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.1::US11242344, Example 114.3 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536256&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572894 464921409 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1136999 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(CC(F)(F)F)C(C)(C)N1)c1cc(C)no1 InChI=1S/C19H28F3N5O3/c1-10(2)15(14-6-11(3)25-30-14)17(29)26-8-12(28)7-13(26)16-23-18(4,5)27(24-16)9-19(20,21)22/h6,10,12-13,15,28H,7-9H2,1-5H3,(H,23,24)/t12-,13+,15?/m1/s1 RMDQNUOGNKJAHB-NEJHNUGDSA-N 536255 1-((2S,4R)-2-(5,5-dimethyl-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 134.1::US11242344, Example 134.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 48200 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536255&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160664859 464921408 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137000 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(CC(F)(F)F)C(C)(C)N1)c1cc(C)no1 InChI=1S/C19H28F3N5O3/c1-10(2)15(14-6-11(3)25-30-14)17(29)26-8-12(28)7-13(26)16-23-18(4,5)27(24-16)9-19(20,21)22/h6,10,12-13,15,28H,7-9H2,1-5H3,(H,23,24)/t12-,13+,15?/m1/s1 RMDQNUOGNKJAHB-NEJHNUGDSA-N 536255 1-((2S,4R)-2-(5,5-dimethyl-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 134.1::US11242344, Example 134.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 57400 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536255&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160664859 464921408 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137001 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(CC(F)(F)F)C(C)(C)N1)c1cc(C)no1 InChI=1S/C19H28F3N5O3/c1-10(2)15(14-6-11(3)25-30-14)17(29)26-8-12(28)7-13(26)16-23-18(4,5)27(24-16)9-19(20,21)22/h6,10,12-13,15,28H,7-9H2,1-5H3,(H,23,24)/t12-,13+,15?/m1/s1 RMDQNUOGNKJAHB-NEJHNUGDSA-N 536255 1-((2S,4R)-2-(5,5-dimethyl-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 134.1::US11242344, Example 134.2 von Hippel-Lindau disease tumor suppressor Human 41300 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536255&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 160664859 464921408 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137002 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21-/m1/s1 VNNBFHMSXBWONC-VWFIUDSGSA-N 536258 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.2::US11242344, Example 114.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536258&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572422 464921410 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137003 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21-/m1/s1 VNNBFHMSXBWONC-VWFIUDSGSA-N 536258 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.2::US11242344, Example 114.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536258&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572422 464921410 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137004 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21-/m1/s1 VNNBFHMSXBWONC-VWFIUDSGSA-N 536258 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.2::US11242344, Example 114.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536258&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572422 464921410 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137005 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(c2ccccc2)C(C)(C)N1)c1cc(C)no1 InChI=1S/C23H31N5O3/c1-14(2)20(19-11-15(3)26-31-19)22(30)27-13-17(29)12-18(27)21-24-23(4,5)28(25-21)16-9-7-6-8-10-16/h6-11,14,17-18,20,29H,12-13H2,1-5H3,(H,24,25)/t17-,18+,20?/m1/s1 YYPSIGSWLYJIDY-ZOVQDZKKSA-N 536259 1-((2S,4R)-2-(5,5-dimethyl-1-phenyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 135.1::US11242344, Example 135.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536259&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 162051597 464921411 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137006 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(c2ccccc2)C(C)(C)N1)c1cc(C)no1 InChI=1S/C23H31N5O3/c1-14(2)20(19-11-15(3)26-31-19)22(30)27-13-17(29)12-18(27)21-24-23(4,5)28(25-21)16-9-7-6-8-10-16/h6-11,14,17-18,20,29H,12-13H2,1-5H3,(H,24,25)/t17-,18+,20?/m1/s1 YYPSIGSWLYJIDY-ZOVQDZKKSA-N 536259 1-((2S,4R)-2-(5,5-dimethyl-1-phenyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 135.1::US11242344, Example 135.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536259&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 162051597 464921411 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137007 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(c2ccccc2)C(C)(C)N1)c1cc(C)no1 InChI=1S/C23H31N5O3/c1-14(2)20(19-11-15(3)26-31-19)22(30)27-13-17(29)12-18(27)21-24-23(4,5)28(25-21)16-9-7-6-8-10-16/h6-11,14,17-18,20,29H,12-13H2,1-5H3,(H,24,25)/t17-,18+,20?/m1/s1 YYPSIGSWLYJIDY-ZOVQDZKKSA-N 536259 1-((2S,4R)-2-(5,5-dimethyl-1-phenyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 135.1::US11242344, Example 135.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536259&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 162051597 464921411 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137008 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21+/m1/s1 VNNBFHMSXBWONC-AWQBJMPUSA-N 536256 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.1::US11242344, Example 114.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 47000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536256&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572894 464921409 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137009 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21+/m1/s1 VNNBFHMSXBWONC-AWQBJMPUSA-N 536256 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.1::US11242344, Example 114.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 8800 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536256&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572894 464921409 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137010 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21+/m1/s1 VNNBFHMSXBWONC-AWQBJMPUSA-N 536256 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.1::US11242344, Example 114.3 von Hippel-Lindau disease tumor suppressor Human 48800 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536256&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572894 464921409 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137011 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(c2ccccc2)C(C)(C)N1)c1cc(C)no1 InChI=1S/C23H31N5O3/c1-14(2)20(19-11-15(3)26-31-19)22(30)27-13-17(29)12-18(27)21-24-23(4,5)28(25-21)16-9-7-6-8-10-16/h6-11,14,17-18,20,29H,12-13H2,1-5H3,(H,24,25)/t17-,18+,20?/m1/s1 YYPSIGSWLYJIDY-ZOVQDZKKSA-N 536259 1-((2S,4R)-2-(5,5-dimethyl-1-phenyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 135.1::US11242344, Example 135.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 9320 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536259&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 162051597 464921411 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137012 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(c2ccccc2)C(C)(C)N1)c1cc(C)no1 InChI=1S/C23H31N5O3/c1-14(2)20(19-11-15(3)26-31-19)22(30)27-13-17(29)12-18(27)21-24-23(4,5)28(25-21)16-9-7-6-8-10-16/h6-11,14,17-18,20,29H,12-13H2,1-5H3,(H,24,25)/t17-,18+,20?/m1/s1 YYPSIGSWLYJIDY-ZOVQDZKKSA-N 536259 1-((2S,4R)-2-(5,5-dimethyl-1-phenyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 135.1::US11242344, Example 135.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 6550 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536259&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 162051597 464921411 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137013 CC(C)C(C(=O)N1C[C@H](O)C[C@H]1C1=NN(c2ccccc2)C(C)(C)N1)c1cc(C)no1 InChI=1S/C23H31N5O3/c1-14(2)20(19-11-15(3)26-31-19)22(30)27-13-17(29)12-18(27)21-24-23(4,5)28(25-21)16-9-7-6-8-10-16/h6-11,14,17-18,20,29H,12-13H2,1-5H3,(H,24,25)/t17-,18+,20?/m1/s1 YYPSIGSWLYJIDY-ZOVQDZKKSA-N 536259 1-((2S,4R)-2-(5,5-dimethyl-1-phenyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 135.1::US11242344, Example 135.2 von Hippel-Lindau disease tumor suppressor Human 5670 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536259&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 162051597 464921411 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137014 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21-/m1/s1 VNNBFHMSXBWONC-VWFIUDSGSA-N 536258 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.2::US11242344, Example 114.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 58300 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536258&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572422 464921410 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137015 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21-/m1/s1 VNNBFHMSXBWONC-VWFIUDSGSA-N 536258 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.2::US11242344, Example 114.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 5860 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536258&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572422 464921410 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137016 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@](N1)(c1ccccc1)C(F)(F)F)c1cc(C)no1 InChI=1S/C22H25F3N4O4/c1-12(2)18(17-9-13(3)27-32-17)20(31)29-11-15(30)10-16(29)19-26-21(33-28-19,22(23,24)25)14-7-5-4-6-8-14/h4-9,12,15-16,18,30H,10-11H2,1-3H3,(H,26,28)/t15-,16+,18-,21-/m1/s1 VNNBFHMSXBWONC-VWFIUDSGSA-N 536258 (2S)-1-((2S,4R)-4-Hydroxy-2-(5-phenyl-5-(trifluoromethyl)-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 114.2::US11242344, Example 114.4 von Hippel-Lindau disease tumor suppressor Human 59900 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536258&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572422 464921410 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137017 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(C)(C)C(C)(C)N1)c1cc(C)no1 InChI=1S/C20H32N4O3/c1-11(2)16(15-8-12(3)23-27-15)18(26)24-10-13(25)9-14(24)17-21-19(4,5)20(6,7)22-17/h8,11,13-14,16,25H,9-10H2,1-7H3,(H,21,22)/t13-,14?,16?/m1/s1 RMPVDBRTXPUCMQ-VQCLRJIVSA-N 536263 1-((4R)-4-Hydroxy-2-(4,4,5,5-tetramethyl-4,5-dihydro-1H-imidazol-2-yl) pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl) butan-1-one (Mixture of 4 Stereoisomers)::US11242344, Example 136.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 93600 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536263&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160668480 464921412 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137018 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(C)(C)C(C)(C)N1)c1cc(C)no1 InChI=1S/C20H32N4O3/c1-11(2)16(15-8-12(3)23-27-15)18(26)24-10-13(25)9-14(24)17-21-19(4,5)20(6,7)22-17/h8,11,13-14,16,25H,9-10H2,1-7H3,(H,21,22)/t13-,14?,16?/m1/s1 RMPVDBRTXPUCMQ-VQCLRJIVSA-N 536263 1-((4R)-4-Hydroxy-2-(4,4,5,5-tetramethyl-4,5-dihydro-1H-imidazol-2-yl) pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl) butan-1-one (Mixture of 4 Stereoisomers)::US11242344, Example 136.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536263&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 160668480 464921412 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137019 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(C)(C)C(C)(C)N1)c1cc(C)no1 InChI=1S/C20H32N4O3/c1-11(2)16(15-8-12(3)23-27-15)18(26)24-10-13(25)9-14(24)17-21-19(4,5)20(6,7)22-17/h8,11,13-14,16,25H,9-10H2,1-7H3,(H,21,22)/t13-,14?,16?/m1/s1 RMPVDBRTXPUCMQ-VQCLRJIVSA-N 536263 1-((4R)-4-Hydroxy-2-(4,4,5,5-tetramethyl-4,5-dihydro-1H-imidazol-2-yl) pyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl) butan-1-one (Mixture of 4 Stereoisomers)::US11242344, Example 136.1 von Hippel-Lindau disease tumor suppressor Human 77100 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536263&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 160668480 464921412 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137020 CCN1N=C(NC1(C)C)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(C)no1 InChI=1S/C19H31N5O3/c1-7-24-19(5,6)20-17(21-24)14-9-13(25)10-23(14)18(26)16(11(2)3)15-8-12(4)22-27-15/h8,11,13-14,16,25H,7,9-10H2,1-6H3,(H,20,21)/t13-,14+,16?/m1/s1 JEBUBKJHZDBEKS-CNYCQXTOSA-N 536264 1-((2S,4R)-2-(1-ethyl-5,5-dimethyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl) butan-1-one (2 Single Stereoisomers)::US11242344, Example 115.1::US11242344, Example 115.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536264&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 148038928 464921413 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137021 CCN1N=C(NC1(C)C)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(C)no1 InChI=1S/C19H31N5O3/c1-7-24-19(5,6)20-17(21-24)14-9-13(25)10-23(14)18(26)16(11(2)3)15-8-12(4)22-27-15/h8,11,13-14,16,25H,7,9-10H2,1-6H3,(H,20,21)/t13-,14+,16?/m1/s1 JEBUBKJHZDBEKS-CNYCQXTOSA-N 536264 1-((2S,4R)-2-(1-ethyl-5,5-dimethyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl) butan-1-one (2 Single Stereoisomers)::US11242344, Example 115.1::US11242344, Example 115.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536264&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 148038928 464921413 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137022 CCN1N=C(NC1(C)C)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(C)no1 InChI=1S/C19H31N5O3/c1-7-24-19(5,6)20-17(21-24)14-9-13(25)10-23(14)18(26)16(11(2)3)15-8-12(4)22-27-15/h8,11,13-14,16,25H,7,9-10H2,1-6H3,(H,20,21)/t13-,14+,16?/m1/s1 JEBUBKJHZDBEKS-CNYCQXTOSA-N 536264 1-((2S,4R)-2-(1-ethyl-5,5-dimethyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl) butan-1-one (2 Single Stereoisomers)::US11242344, Example 115.1::US11242344, Example 115.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536264&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 148038928 464921413 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137023 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NS(=O)(=O)CN1)c1cc(C)no1 InChI=1S/C15H22N4O5S/c1-8(2)13(12-4-9(3)17-24-12)15(21)19-6-10(20)5-11(19)14-16-7-25(22,23)18-14/h4,8,10-11,13,20H,5-7H2,1-3H3,(H,16,18)/t10-,11+,13-/m1/s1 ICHGUTYOUFXFKE-NTZNESFSSA-N 536265 1-((4R)-2-(1,1-dioxido-4,5-dihydro-1,2,4-thiadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 137.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536265&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572816 464921414 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137024 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C1=NS(=O)(=O)CN1)c1cc(C)no1 InChI=1S/C15H22N4O5S/c1-8(2)13(12-4-9(3)17-24-12)15(21)19-6-10(20)5-11(19)14-16-7-25(22,23)18-14/h4,8,10-11,13,20H,5-7H2,1-3H3,(H,16,18)/t10-,11+,13-/m1/s1 ICHGUTYOUFXFKE-NTZNESFSSA-N 536265 1-((4R)-2-(1,1-dioxido-4,5-dihydro-1,2,4-thiadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::US11242344, Example 137.1 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536265&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572816 464921414 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137025 CCN1N=C(NC1(C)C)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(C)no1 InChI=1S/C19H31N5O3/c1-7-24-19(5,6)20-17(21-24)14-9-13(25)10-23(14)18(26)16(11(2)3)15-8-12(4)22-27-15/h8,11,13-14,16,25H,7,9-10H2,1-6H3,(H,20,21)/t13-,14+,16?/m1/s1 JEBUBKJHZDBEKS-CNYCQXTOSA-N 536264 1-((2S,4R)-2-(1-ethyl-5,5-dimethyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl) butan-1-one (2 Single Stereoisomers)::US11242344, Example 115.1::US11242344, Example 115.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 40700 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536264&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 148038928 464921413 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137026 CCN1N=C(NC1(C)C)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(C)no1 InChI=1S/C19H31N5O3/c1-7-24-19(5,6)20-17(21-24)14-9-13(25)10-23(14)18(26)16(11(2)3)15-8-12(4)22-27-15/h8,11,13-14,16,25H,7,9-10H2,1-6H3,(H,20,21)/t13-,14+,16?/m1/s1 JEBUBKJHZDBEKS-CNYCQXTOSA-N 536264 1-((2S,4R)-2-(1-ethyl-5,5-dimethyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl) butan-1-one (2 Single Stereoisomers)::US11242344, Example 115.1::US11242344, Example 115.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 4030 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536264&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 148038928 464921413 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137027 CCN1N=C(NC1(C)C)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(C)no1 InChI=1S/C19H31N5O3/c1-7-24-19(5,6)20-17(21-24)14-9-13(25)10-23(14)18(26)16(11(2)3)15-8-12(4)22-27-15/h8,11,13-14,16,25H,7,9-10H2,1-6H3,(H,20,21)/t13-,14+,16?/m1/s1 JEBUBKJHZDBEKS-CNYCQXTOSA-N 536264 1-((2S,4R)-2-(1-ethyl-5,5-dimethyl-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl) butan-1-one (2 Single Stereoisomers)::US11242344, Example 115.1::US11242344, Example 115.2 von Hippel-Lindau disease tumor suppressor Human 25700 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536264&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 148038928 464921413 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137028 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NS(=O)(=O)CN1)c1cc(C)no1 InChI=1S/C15H22N4O5S/c1-8(2)13(12-4-9(3)17-24-12)15(21)19-6-10(20)5-11(19)14-16-7-25(22,23)18-14/h4,8,10-11,13,20H,5-7H2,1-3H3,(H,16,18)/t10-,11-,13-/m1/s1 ICHGUTYOUFXFKE-NQBHXWOUSA-N 536267 US11242344, Example 137.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 47300 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536267&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572579 464921415 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137029 CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NS(=O)(=O)CN1)c1cc(C)no1 InChI=1S/C15H22N4O5S/c1-8(2)13(12-4-9(3)17-24-12)15(21)19-6-10(20)5-11(19)14-16-7-25(22,23)18-14/h4,8,10-11,13,20H,5-7H2,1-3H3,(H,16,18)/t10-,11-,13-/m1/s1 ICHGUTYOUFXFKE-NQBHXWOUSA-N 536267 US11242344, Example 137.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536267&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572579 464921415 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137030 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(O)no1 InChI=1S/C26H29N5O5S/c1-13(2)21(19-10-20(33)30-36-19)24(34)31-11-17(32)9-18(31)23-28-25(35)26(4,29-23)16-7-5-15(6-8-16)22-14(3)27-12-37-22/h5-8,10,12-13,17-18,21,32H,9,11H2,1-4H3,(H,30,33)(H,28,29,35)/t17-,18?,21?,26+/m1/s1 GLUULBFXJUHCEP-INQDGJAXSA-N 536268 (5S)-2-((4R)-4-hydroxy-1-(2-(3-hydroxyisoxazol-5- yl)-3-methylbutanoyl)pyrrolidin-2-yl)-5-methyl-5-(4- (4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H- imidazol-4-one::US11242344, Example 116.1::US11242344, Example 116.2::US11242344, Example 116.3::US11242344, Example 116.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 4350 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536268&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572522 464921416 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137031 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(O)no1 InChI=1S/C26H29N5O5S/c1-13(2)21(19-10-20(33)30-36-19)24(34)31-11-17(32)9-18(31)23-28-25(35)26(4,29-23)16-7-5-15(6-8-16)22-14(3)27-12-37-22/h5-8,10,12-13,17-18,21,32H,9,11H2,1-4H3,(H,30,33)(H,28,29,35)/t17-,18?,21?,26+/m1/s1 GLUULBFXJUHCEP-INQDGJAXSA-N 536268 (5S)-2-((4R)-4-hydroxy-1-(2-(3-hydroxyisoxazol-5- yl)-3-methylbutanoyl)pyrrolidin-2-yl)-5-methyl-5-(4- (4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H- imidazol-4-one::US11242344, Example 116.1::US11242344, Example 116.2::US11242344, Example 116.3::US11242344, Example 116.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 5100 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536268&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572522 464921416 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137032 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(O)no1 InChI=1S/C26H29N5O5S/c1-13(2)21(19-10-20(33)30-36-19)24(34)31-11-17(32)9-18(31)23-28-25(35)26(4,29-23)16-7-5-15(6-8-16)22-14(3)27-12-37-22/h5-8,10,12-13,17-18,21,32H,9,11H2,1-4H3,(H,30,33)(H,28,29,35)/t17-,18?,21?,26+/m1/s1 GLUULBFXJUHCEP-INQDGJAXSA-N 536268 (5S)-2-((4R)-4-hydroxy-1-(2-(3-hydroxyisoxazol-5- yl)-3-methylbutanoyl)pyrrolidin-2-yl)-5-methyl-5-(4- (4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H- imidazol-4-one::US11242344, Example 116.1::US11242344, Example 116.2::US11242344, Example 116.3::US11242344, Example 116.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536268&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572522 464921416 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137033 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NS(=O)(=O)CN1)c1cc(C)no1 InChI=1S/C15H22N4O5S/c1-8(2)13(12-4-9(3)17-24-12)15(21)19-6-10(20)5-11(19)14-16-7-25(22,23)18-14/h4,8,10-11,13,20H,5-7H2,1-3H3,(H,16,18)/t10-,11+,13+/m1/s1 ICHGUTYOUFXFKE-MDZLAQPJSA-N 536269 US11242344, Example 137.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536269&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572457 464921417 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137034 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NS(=O)(=O)CN1)c1cc(C)no1 InChI=1S/C15H22N4O5S/c1-8(2)13(12-4-9(3)17-24-12)15(21)19-6-10(20)5-11(19)14-16-7-25(22,23)18-14/h4,8,10-11,13,20H,5-7H2,1-3H3,(H,16,18)/t10-,11+,13+/m1/s1 ICHGUTYOUFXFKE-MDZLAQPJSA-N 536269 US11242344, Example 137.3 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536269&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572457 464921417 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137035 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(O)no1 InChI=1S/C26H29N5O5S/c1-13(2)21(19-10-20(33)30-36-19)24(34)31-11-17(32)9-18(31)23-28-25(35)26(4,29-23)16-7-5-15(6-8-16)22-14(3)27-12-37-22/h5-8,10,12-13,17-18,21,32H,9,11H2,1-4H3,(H,30,33)(H,28,29,35)/t17-,18?,21?,26+/m1/s1 GLUULBFXJUHCEP-INQDGJAXSA-N 536268 (5S)-2-((4R)-4-hydroxy-1-(2-(3-hydroxyisoxazol-5- yl)-3-methylbutanoyl)pyrrolidin-2-yl)-5-methyl-5-(4- (4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H- imidazol-4-one::US11242344, Example 116.1::US11242344, Example 116.2::US11242344, Example 116.3::US11242344, Example 116.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536268&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572522 464921416 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137036 CC(C)C(C(=O)N1C[C@@H](C[C@H]1C1=NOC(C)(N1)c1ccc(Br)cc1)O[Si](C)(C)C(C)(C)C)c1cc(C)no1 InChI=1S/C28H41BrN4O4Si/c1-17(2)24(23-14-18(3)31-35-23)26(34)33-16-21(36-38(8,9)27(4,5)6)15-22(33)25-30-28(7,37-32-25)19-10-12-20(29)13-11-19/h10-14,17,21-22,24H,15-16H2,1-9H3,(H,30,32)/t21-,22+,24?,28?/m1/s1 ZODMTQOCDYVPAH-ROGCHJSCSA-N 536271 1-((2S,4R)-2-((R)-5-(2′-fluoro-[1,1′-biphenyl]-4-yl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one (2 Stereoisomers)::US11242344, Example 139.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 10000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536271&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 162468871 464921418 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137037 CC(C)C(C(=O)N1C[C@@H](C[C@H]1C1=NOC(C)(N1)c1ccc(Br)cc1)O[Si](C)(C)C(C)(C)C)c1cc(C)no1 InChI=1S/C28H41BrN4O4Si/c1-17(2)24(23-14-18(3)31-35-23)26(34)33-16-21(36-38(8,9)27(4,5)6)15-22(33)25-30-28(7,37-32-25)19-10-12-20(29)13-11-19/h10-14,17,21-22,24H,15-16H2,1-9H3,(H,30,32)/t21-,22+,24?,28?/m1/s1 ZODMTQOCDYVPAH-ROGCHJSCSA-N 536271 1-((2S,4R)-2-((R)-5-(2′-fluoro-[1,1′-biphenyl]-4-yl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one (2 Stereoisomers)::US11242344, Example 139.1 von Hippel-Lindau disease tumor suppressor Human 21700 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536271&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 162468871 464921418 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137038 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(O)no1 InChI=1S/C26H29N5O5S/c1-13(2)21(19-10-20(33)30-36-19)24(34)31-11-17(32)9-18(31)23-28-25(35)26(4,29-23)16-7-5-15(6-8-16)22-14(3)27-12-37-22/h5-8,10,12-13,17-18,21,32H,9,11H2,1-4H3,(H,30,33)(H,28,29,35)/t17-,18?,21?,26+/m1/s1 GLUULBFXJUHCEP-INQDGJAXSA-N 536268 (5S)-2-((4R)-4-hydroxy-1-(2-(3-hydroxyisoxazol-5- yl)-3-methylbutanoyl)pyrrolidin-2-yl)-5-methyl-5-(4- (4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H- imidazol-4-one::US11242344, Example 116.1::US11242344, Example 116.2::US11242344, Example 116.3::US11242344, Example 116.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536268&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572522 464921416 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137039 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19+,22-/m1/s1 WEBARINGELPABF-NIRMNWTQSA-N 536252 (2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::BDBM536273::US11242344, Example 113.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 62.8 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536252&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572784 464921406 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137040 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@H]1C1=NO[C@@](C)(N1)c1ccc(Br)cc1)c1cc(C)no1 InChI=1S/C22H27BrN4O4/c1-12(2)19(18-9-13(3)25-30-18)21(29)27-11-16(28)10-17(27)20-24-22(4,31-26-20)14-5-7-15(23)8-6-14/h5-9,12,16-17,19,28H,10-11H2,1-4H3,(H,24,26)/t16-,17+,19+,22-/m1/s1 WEBARINGELPABF-NIRMNWTQSA-N 536252 (2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one::BDBM536273::US11242344, Example 113.3 von Hippel-Lindau disease tumor suppressor Human 67.8 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536252&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572784 464921406 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137041 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(O)no1 InChI=1S/C26H29N5O5S/c1-13(2)21(19-10-20(33)30-36-19)24(34)31-11-17(32)9-18(31)23-28-25(35)26(4,29-23)16-7-5-15(6-8-16)22-14(3)27-12-37-22/h5-8,10,12-13,17-18,21,32H,9,11H2,1-4H3,(H,30,33)(H,28,29,35)/t17-,18?,21?,26+/m1/s1 GLUULBFXJUHCEP-INQDGJAXSA-N 536268 (5S)-2-((4R)-4-hydroxy-1-(2-(3-hydroxyisoxazol-5- yl)-3-methylbutanoyl)pyrrolidin-2-yl)-5-methyl-5-(4- (4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H- imidazol-4-one::US11242344, Example 116.1::US11242344, Example 116.2::US11242344, Example 116.3::US11242344, Example 116.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 35400 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536268&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572522 464921416 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137042 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(O)no1 InChI=1S/C26H29N5O5S/c1-13(2)21(19-10-20(33)30-36-19)24(34)31-11-17(32)9-18(31)23-28-25(35)26(4,29-23)16-7-5-15(6-8-16)22-14(3)27-12-37-22/h5-8,10,12-13,17-18,21,32H,9,11H2,1-4H3,(H,30,33)(H,28,29,35)/t17-,18?,21?,26+/m1/s1 GLUULBFXJUHCEP-INQDGJAXSA-N 536268 (5S)-2-((4R)-4-hydroxy-1-(2-(3-hydroxyisoxazol-5- yl)-3-methylbutanoyl)pyrrolidin-2-yl)-5-methyl-5-(4- (4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H- imidazol-4-one::US11242344, Example 116.1::US11242344, Example 116.2::US11242344, Example 116.3::US11242344, Example 116.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 5300 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536268&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572522 464921416 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137043 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(O)no1 InChI=1S/C26H29N5O5S/c1-13(2)21(19-10-20(33)30-36-19)24(34)31-11-17(32)9-18(31)23-28-25(35)26(4,29-23)16-7-5-15(6-8-16)22-14(3)27-12-37-22/h5-8,10,12-13,17-18,21,32H,9,11H2,1-4H3,(H,30,33)(H,28,29,35)/t17-,18?,21?,26+/m1/s1 GLUULBFXJUHCEP-INQDGJAXSA-N 536268 (5S)-2-((4R)-4-hydroxy-1-(2-(3-hydroxyisoxazol-5- yl)-3-methylbutanoyl)pyrrolidin-2-yl)-5-methyl-5-(4- (4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H- imidazol-4-one::US11242344, Example 116.1::US11242344, Example 116.2::US11242344, Example 116.3::US11242344, Example 116.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536268&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572522 464921416 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137044 CC(C)[C@@H](C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(OCCCCCNC(=O)c2cc3N(Cc4c[nH]c5c4c(cn(C)c5=O)-c3cc2CS(C)(=O)=O)c2ncc(F)cc2F)no1 536275 US11242344, Example 1001.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 16900 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536275&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407789 464921420 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137045 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137046 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 155000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137047 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137048 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)C(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(OCCCCCNC(=O)c2cc3N(Cc4c[nH]c5c4c(cn(C)c5=O)-c3cc2CS(C)(=O)=O)c2ncc(F)cc2F)no1 536277 US11242344, Example 1001.2::US11242344, Example 1001.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 795 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536277&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407790 464921422 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137049 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 1620 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137050 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 625 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137051 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 von Hippel-Lindau disease tumor suppressor Human 1900 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137052 CC(C)[C@H](C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)C(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(OCCCCCNC(=O)c2cc3N(Cc4c[nH]c5c4c(cn(C)c5=O)-c3cc2CS(C)(=O)=O)c2ncc(F)cc2F)no1 536277 US11242344, Example 1001.2::US11242344, Example 1001.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >100000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536277&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407790 464921422 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137053 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137054 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 217000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137055 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137056 CC(C)[C@H](C(=O)N1C[C@H](O)CC1C1=NC(=O)C(C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(OCCCCCNC(=O)c2cc3N(Cc4c[nH]c5c4c(cn(C)c5=O)-c3cc2CS(C)(=O)=O)c2ncc(F)cc2F)no1 536281 US11242344, Example 1001.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human >100000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536281&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 163407791 464921423 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137057 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137058 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137059 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1nc(C)no1 InChI=1S/C26H30N6O4S/c1-13(2)20(23-28-15(4)31-36-23)24(34)32-11-18(33)10-19(32)22-29-25(35)26(5,30-22)17-8-6-16(7-9-17)21-14(3)27-12-37-21/h6-9,12-13,18-20,33H,10-11H2,1-5H3,(H,29,30,35)/t18-,19?,20?,26+/m1/s1 PECICTZKVKHDTH-WJSHSNFHSA-N 536276 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 117.1::US11242344, Example 117.2::US11242344, Example 117.3::US11242344, Example 117.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536276&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572445 464921421 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137060 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@@H](C(C)C)C(=O)N2C[C@H](O)C[C@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47+,51-,57+/m1/s1 YNNSZAHUAIODTC-HJTABLSOSA-N 536283 4-(2-((5-(1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)isoxazol-3-yl)oxy)ethoxy)-N-(2-(4-((Z)-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenoxy)ethyl)-N-methylbutanamide::US11242344, Example 1003.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536283&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 161964412 464921424 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137061 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@@H](C(C)C)C(=O)N2C[C@H](O)C[C@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47+,51-,57+/m1/s1 YNNSZAHUAIODTC-HJTABLSOSA-N 536283 4-(2-((5-(1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)isoxazol-3-yl)oxy)ethoxy)-N-(2-(4-((Z)-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenoxy)ethyl)-N-methylbutanamide::US11242344, Example 1003.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 67100 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536283&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 161964412 464921424 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137062 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@@H](C(C)C)C(=O)N2C[C@H](O)C[C@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47+,51-,57+/m1/s1 YNNSZAHUAIODTC-HJTABLSOSA-N 536283 4-(2-((5-(1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)isoxazol-3-yl)oxy)ethoxy)-N-(2-(4-((Z)-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenoxy)ethyl)-N-methylbutanamide::US11242344, Example 1003.1 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536283&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 161964412 464921424 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137063 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 157000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137064 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 61500 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137065 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137066 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@@H](C(C)C)C(=O)N2C[C@H](O)C[C@@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47-,51-,57+/m1/s1 YNNSZAHUAIODTC-FHSUYOSUSA-N 536285 US11242344, Example 1003.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536285&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 161964411 464921426 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137067 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@@H](C(C)C)C(=O)N2C[C@H](O)C[C@@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47-,51-,57+/m1/s1 YNNSZAHUAIODTC-FHSUYOSUSA-N 536285 US11242344, Example 1003.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 67100 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536285&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 161964411 464921426 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137068 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@@H](C(C)C)C(=O)N2C[C@H](O)C[C@@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47-,51-,57+/m1/s1 YNNSZAHUAIODTC-FHSUYOSUSA-N 536285 US11242344, Example 1003.2 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536285&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 161964411 464921426 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137069 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 418 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137070 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 128 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137071 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 von Hippel-Lindau disease tumor suppressor Human 939 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137072 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@H](C(C)C)C(=O)N2C[C@H](O)C[C@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47+,51+,57+/m1/s1 YNNSZAHUAIODTC-SZPJVTDJSA-N 536287 US11242344, Example 1003.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 30400 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536287&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572698 464921427 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137073 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@H](C(C)C)C(=O)N2C[C@H](O)C[C@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47+,51+,57+/m1/s1 YNNSZAHUAIODTC-SZPJVTDJSA-N 536287 US11242344, Example 1003.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 67100 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536287&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572698 464921427 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137074 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@H](C(C)C)C(=O)N2C[C@H](O)C[C@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47+,51+,57+/m1/s1 YNNSZAHUAIODTC-SZPJVTDJSA-N 536287 US11242344, Example 1003.3 von Hippel-Lindau disease tumor suppressor Human 51600 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536287&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572698 464921427 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137075 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137076 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 21200 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137077 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137078 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@H](C(C)C)C(=O)N2C[C@H](O)C[C@@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47-,51+,57+/m1/s1 YNNSZAHUAIODTC-HTCPFQGRSA-N 536289 US11242344, Example 1003.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 100000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536289&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572591 464921428 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137079 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@H](C(C)C)C(=O)N2C[C@H](O)C[C@@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47-,51+,57+/m1/s1 YNNSZAHUAIODTC-HTCPFQGRSA-N 536289 US11242344, Example 1003.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 67100 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536289&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572591 464921428 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137080 CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C(=O)CCCOCCOc2cc(on2)[C@H](C(C)C)C(=O)N2C[C@H](O)C[C@@H]2C2=NC(=O)[C@@](C)(N2)c2ccc(cc2)-c2scnc2C)cc1)c1ccccc1 InChI=1S/C57H64N6O9S/c1-7-46(38-12-9-8-10-13-38)52(39-17-23-43(64)24-18-39)40-19-25-45(26-20-40)70-29-27-62(6)50(66)14-11-28-69-30-31-71-49-33-48(72-61-49)51(36(2)3)55(67)63-34-44(65)32-47(63)54-59-56(68)57(5,60-54)42-21-15-41(16-22-42)53-37(4)58-35-73-53/h8-10,12-13,15-26,33,35-36,44,47,51,64-65H,7,11,14,27-32,34H2,1-6H3,(H,59,60,68)/b52-46-/t44-,47-,51+,57+/m1/s1 YNNSZAHUAIODTC-HTCPFQGRSA-N 536289 US11242344, Example 1003.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536289&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572591 464921428 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137081 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137082 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 102000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137083 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cn(C)nn1 InChI=1S/C26H31N7O3S/c1-14(2)21(19-12-32(5)31-30-19)24(35)33-11-18(34)10-20(33)23-28-25(36)26(4,29-23)17-8-6-16(7-9-17)22-15(3)27-13-37-22/h6-9,12-14,18,20-21,34H,10-11H2,1-5H3,(H,28,29,36)/t18-,20?,21?,26+/m1/s1 ZXSIYBHMUJKMEO-GFWDKJHQSA-N 536284 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 118.1::US11242344, Example 118.2::US11242344, Example 118.3::US11242344, Example 118.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536284&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572548 464921425 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137084 COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOCC#CC#CCOc1cc(on1)[C@@H](C(C)C)C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C53H52N8O9S/c1-7-35-13-12-14-38(25-35)57-49-40-27-43(44(67-23-21-65-6)28-41(40)54-31-55-49)68-24-22-66-19-10-8-9-11-20-69-46-29-45(70-60-46)47(33(2)3)51(63)61-30-39(62)26-42(61)50-58-52(64)53(5,59-50)37-17-15-36(16-18-37)48-34(4)56-32-71-48/h1,12-18,25,27-29,31-33,39,42,47,62H,19-24,26,30H2,2-6H3,(H,54,55,57)(H,58,59,64)/t39-,42+,47-,53+/m1/s1 GDUPOTCODJXPBK-FZCWASTKSA-N 536291 (5S)-2-((4R)-1-(2-(3-((6-(2-((4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethoxy)hexa-2,4-diyn-1-yl)oxy)isoxazol-5-yl)-3-methylbutanoyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one ::US11242344, Example 1004.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 6250 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536291&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 158226001 464921429 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137085 COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOCC#CC#CCOc1cc(on1)[C@@H](C(C)C)C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C53H52N8O9S/c1-7-35-13-12-14-38(25-35)57-49-40-27-43(44(67-23-21-65-6)28-41(40)54-31-55-49)68-24-22-66-19-10-8-9-11-20-69-46-29-45(70-60-46)47(33(2)3)51(63)61-30-39(62)26-42(61)50-58-52(64)53(5,59-50)37-17-15-36(16-18-37)48-34(4)56-32-71-48/h1,12-18,25,27-29,31-33,39,42,47,62H,19-24,26,30H2,2-6H3,(H,54,55,57)(H,58,59,64)/t39-,42+,47-,53+/m1/s1 GDUPOTCODJXPBK-FZCWASTKSA-N 536291 (5S)-2-((4R)-1-(2-(3-((6-(2-((4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethoxy)hexa-2,4-diyn-1-yl)oxy)isoxazol-5-yl)-3-methylbutanoyl)-4-hydroxypyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one ::US11242344, Example 1004.1 von Hippel-Lindau disease tumor suppressor Human 68300 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536291&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 158226001 464921429 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137086 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137087 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137088 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137089 COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOCC#CC#CCOc1cc(on1)[C@@H](C(C)C)C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C53H52N8O9S/c1-7-35-13-12-14-38(25-35)57-49-40-27-43(44(67-23-21-65-6)28-41(40)54-31-55-49)68-24-22-66-19-10-8-9-11-20-69-46-29-45(70-60-46)47(33(2)3)51(63)61-30-39(62)26-42(61)50-58-52(64)53(5,59-50)37-17-15-36(16-18-37)48-34(4)56-32-71-48/h1,12-18,25,27-29,31-33,39,42,47,62H,19-24,26,30H2,2-6H3,(H,54,55,57)(H,58,59,64)/t39-,42-,47-,53+/m1/s1 GDUPOTCODJXPBK-MHHUAASLSA-N 536293 US11242344, Example 1004.2 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 75800 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536293&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 158226004 464921431 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137090 COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOCC#CC#CCOc1cc(on1)[C@@H](C(C)C)C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C53H52N8O9S/c1-7-35-13-12-14-38(25-35)57-49-40-27-43(44(67-23-21-65-6)28-41(40)54-31-55-49)68-24-22-66-19-10-8-9-11-20-69-46-29-45(70-60-46)47(33(2)3)51(63)61-30-39(62)26-42(61)50-58-52(64)53(5,59-50)37-17-15-36(16-18-37)48-34(4)56-32-71-48/h1,12-18,25,27-29,31-33,39,42,47,62H,19-24,26,30H2,2-6H3,(H,54,55,57)(H,58,59,64)/t39-,42-,47-,53+/m1/s1 GDUPOTCODJXPBK-MHHUAASLSA-N 536293 US11242344, Example 1004.2 von Hippel-Lindau disease tumor suppressor Human 46400 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536293&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 158226004 464921431 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137091 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137092 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137093 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137094 COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOCC#CC#CCOc1cc(on1)[C@H](C(C)C)C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C53H52N8O9S/c1-7-35-13-12-14-38(25-35)57-49-40-27-43(44(67-23-21-65-6)28-41(40)54-31-55-49)68-24-22-66-19-10-8-9-11-20-69-46-29-45(70-60-46)47(33(2)3)51(63)61-30-39(62)26-42(61)50-58-52(64)53(5,59-50)37-17-15-36(16-18-37)48-34(4)56-32-71-48/h1,12-18,25,27-29,31-33,39,42,47,62H,19-24,26,30H2,2-6H3,(H,54,55,57)(H,58,59,64)/t39-,42+,47+,53+/m1/s1 GDUPOTCODJXPBK-IKOGVKPPSA-N 536295 US11242344, Example 1004.3 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 75800 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536295&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 158226002 464921432 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137095 COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOCC#CC#CCOc1cc(on1)[C@H](C(C)C)C(=O)N1C[C@H](O)C[C@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C53H52N8O9S/c1-7-35-13-12-14-38(25-35)57-49-40-27-43(44(67-23-21-65-6)28-41(40)54-31-55-49)68-24-22-66-19-10-8-9-11-20-69-46-29-45(70-60-46)47(33(2)3)51(63)61-30-39(62)26-42(61)50-58-52(64)53(5,59-50)37-17-15-36(16-18-37)48-34(4)56-32-71-48/h1,12-18,25,27-29,31-33,39,42,47,62H,19-24,26,30H2,2-6H3,(H,54,55,57)(H,58,59,64)/t39-,42+,47+,53+/m1/s1 GDUPOTCODJXPBK-IKOGVKPPSA-N 536295 US11242344, Example 1004.3 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536295&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 158226002 464921432 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137096 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 72400 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137097 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 17500 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137098 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 von Hippel-Lindau disease tumor suppressor Human 71100 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137099 COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOCC#CC#CCOc1cc(on1)[C@H](C(C)C)C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C53H52N8O9S/c1-7-35-13-12-14-38(25-35)57-49-40-27-43(44(67-23-21-65-6)28-41(40)54-31-55-49)68-24-22-66-19-10-8-9-11-20-69-46-29-45(70-60-46)47(33(2)3)51(63)61-30-39(62)26-42(61)50-58-52(64)53(5,59-50)37-17-15-36(16-18-37)48-34(4)56-32-71-48/h1,12-18,25,27-29,31-33,39,42,47,62H,19-24,26,30H2,2-6H3,(H,54,55,57)(H,58,59,64)/t39-,42-,47+,53+/m1/s1 GDUPOTCODJXPBK-JTZWRRJCSA-N 536297 US11242344, Example 1004.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 6250 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536297&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 158226003 464921433 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137100 COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOCC#CC#CCOc1cc(on1)[C@H](C(C)C)C(=O)N1C[C@H](O)C[C@@H]1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C InChI=1S/C53H52N8O9S/c1-7-35-13-12-14-38(25-35)57-49-40-27-43(44(67-23-21-65-6)28-41(40)54-31-55-49)68-24-22-66-19-10-8-9-11-20-69-46-29-45(70-60-46)47(33(2)3)51(63)61-30-39(62)26-42(61)50-58-52(64)53(5,59-50)37-17-15-36(16-18-37)48-34(4)56-32-71-48/h1,12-18,25,27-29,31-33,39,42,47,62H,19-24,26,30H2,2-6H3,(H,54,55,57)(H,58,59,64)/t39-,42-,47+,53+/m1/s1 GDUPOTCODJXPBK-JTZWRRJCSA-N 536297 US11242344, Example 1004.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536297&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 158226003 464921433 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137101 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 400000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137102 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 150000 US Patent 10.7270/Q2KW5K7X aid1806328 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137103 CC(C)C(C(=O)N1C[C@H](O)CC1C1=NC(=O)[C@@](C)(N1)c1ccc(cc1)-c1scnc1C)c1cc(C)ns1 InChI=1S/C27H31N5O3S2/c1-14(2)22(21-10-15(3)31-37-21)25(34)32-12-19(33)11-20(32)24-29-26(35)27(5,30-24)18-8-6-17(7-9-18)23-16(4)28-13-36-23/h6-10,13-14,19-20,22,33H,11-12H2,1-5H3,(H,29,30,35)/t19-,20?,22?,27+/m1/s1 MYIXYADVBFWYDM-OURBLFPKSA-N 536292 (5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methylisothiazol-5-yl)butanoyl)pyrrolidin-2-yl)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-1,5-dihydro-4H-imidazol-4-one::US11242344, Example 119.1::US11242344, Example 119.2::US11242344, Example 119.3::US11242344, Example 119.4 von Hippel-Lindau disease tumor suppressor Human 100000 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536292&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572578 464921430 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 1137104 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)c1cc2N(Cc3c[nH]c4c3c(cn(C)c4=O)-c2cc1CS(C)(=O)=O)c1ncc(F)cc1F)C(C)(C)C 536299 4-(3,5-difluoropyridin-2-yl)-N-(11-(((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-11-oxoundecyl)-10-methyl-7-((methylsulfonyl)methyl)-11-oxo-3,4,10,11-tetrahydro-1H-1,4,10-triazadibenzo[cd,f]azulene-6-carboxamide (2 Single Diastereomers)::US11242344, Example 1005.1 Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] Human 255000 US Patent 10.7270/Q2KW5K7X aid1806327 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=270&target=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536299&enzyme=Elongin-B%2FElongin-C+%5B17-112%5D%2Fvon+Hippel-Lindau+disease+tumor+suppressor+%5B55-213%5D&column=ki&startPg=0&Increment=50&submit=Search 142572383 464921434 3 EAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1LQB,1VCB,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I7Q,6I7R,6R6H,6R7F,6SIS,7CJB,7JTO,7JTP,7KHH,7Q2J,7S4E,7Z6L,7Z76,7Z77,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8G1P,8G1Q,8P0F von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9 MYVKLISSDGHEFIVKREHALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFPIAPEIALELLMAANFLDC 1LM8,1LQB,1VCB,2C9W,2FNJ,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R7F,6R7H,6R7N,6SIS,6V9H,7CJB,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7SHK,7SHL,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-C ELOC_HUMAN Q15369 E5RGD9 Q567Q6 MDVFLMIRRHKTTIFTDAKESSTVFELKRIVEGILKRPPDEQRLYKDDQLLDDGKTLGECGFTSQTARPQAPATVGLAFRADDTFEALCIEPFSSPPELPDVMKPQDSGSSANEQAVQ 1LM8,1LQB,1VCB,2C9W,2IZV,2JZ3,2MA9,3DCG,3ZKJ,3ZNG,3ZRC,3ZRF,3ZTC,3ZTD,3ZUN,4AJY,4AWJ,4B95,4B9K,4BKS,4BKT,4N9F,4W9C,4W9D,4W9E,4W9F,4W9G,4W9H,4W9I,4W9J,4W9K,4W9L,4WQO,5BO4,5LLI,5N4W,5NVV,5NVW,5NVX,5NVY,5NVZ,5NW0,5NW1,5NW2,5T35,6BVB,6C5X,6FMI,6FMJ,6FMK,6GFX,6GFY,6GFZ,6GMN,6GMQ,6GMR,6GMX,6HAX,6HAY,6HR2,6I4X,6I5J,6I5N,6I7Q,6I7R,6P59,6R6H,6R7F,6R7H,6R7I,6R7N,6SIS,6V9H,7JTO,7JTP,7KHH,7M6T,7PLO,7Q2J,7S4E,7UPN,7Z6L,7Z76,7Z77,7ZLM,7ZLN,7ZLO,7ZLP,7ZLR,7ZLS,7ZNT,8BB2,8BB3,8BB4,8BB5,8BDI,8BDJ,8BDL,8BDM,8BDN,8BDO,8BDS,8BDT,8BDX,8BEB,8C13,8CX0,8CX1,8CX2,8EBN,8G1P,8G1Q,8P0F Elongin-B ELOB_HUMAN Q15370 B7WPD3 1137105 Cc1ncsc1-c1ccc(cc1)[C@]1(C)NC(=NC1=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)c1cc2N(Cc3c[nH]c4c3c(cn(C)c4=O)-c2cc1CS(C)(=O)=O)c1ncc(F)cc1F)C(C)(C)C 536299 4-(3,5-difluoropyridin-2-yl)-N-(11-(((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-methylthiazol-5-yl)phenyl)-4-oxo-4,5-dihydro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-11-oxoundecyl)-10-methyl-7-((methylsulfonyl)methyl)-11-oxo-3,4,10,11-tetrahydro-1H-1,4,10-triazadibenzo[cd,f]azulene-6-carboxamide (2 Single Diastereomers)::US11242344, Example 1005.1 von Hippel-Lindau disease tumor suppressor Human 64600 US Patent 10.7270/Q2KW5K7X aid1806329 US11242344 Blaquiere, N; Dragovich, P; Gazzard, LJ; Pillow, T; Staben, ST; Wei, B; Xin, J 2/8/2022 6/10/2022 Genentech, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=536299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=536299&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search 142572383 464921434 1 MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD 1LM8,1VCB,4B9K,4WQO,5N4W,6FMI,6FMJ,6FMK,6GFX,6HR2,6I7Q,6I7R,6R6H,6R7F,7CJB,7KHH,7Q2J,8C13 von Hippel-Lindau disease tumor suppressor VHL_HUMAN P40337 B2RE45 Q13599 Q6PDA9